Profiles

Gregory Woods

UTAS Home Professor Greg Woods

Greg Woods

Principal Research Fellow

Room 437C, Medical Science 2 (MS2), Hobart CBD Campuses

+61 3 6226 4832 (phone)

G.M.Woods@utas.edu.au

Greg Woods is a Professor of immunology at the School of Medicine and a Principal Research Fellow at the Menzies Institute for Medical Research. He teaches immunology and his research involves the immunology of Devil Facial Tumour Disease (DFTD). In 2011, as part of a five-member team, he was awarded the Sherman Eureka Award for Environmental Science and received a Fellowship of the Faculty of Science, Royal College of Pathologists of Australasia; and in 2015 received The Australian Society for Medical Research Certificate in Recognition of Distinguished Service to Medicine, Science and Community.

Career summary

Qualifications

  • FFSc (RCPA), Royal College of Pathologists of Australasia, Australia. 2011 
  • PhD, University of Tasmania, Australia. 1984 Thesis: Studies on Human T Lymphocyte Colonies
  • BSc (Hons), Monash University, Australia. 1978 Thesis: Biology of Actin-like Tissue

Biography

Professor Greg Woods completed a BSc (Hons) undergraduate degree in 1978, at Monash University and completed postgraduate (PhD) degree at the University of Tasmania, in 1984. In 1985 worked as a junior research fellow at the Department of Medicine, University of Tasmania.  For the next two years he was at the Mt. Sinai Hospital Research institute, Toronto Canada as postdoctoral fellow. In 1989 he obtained a lectureship at the University of Tasmania and was promoted to professor in January 2013. In 1993 he was a visiting scientist at the Clinical Research Centre, Northwick Park Hospital, Harrow, England and in 2003 a visiting scientist  at the University of Edinburgh, Edinburgh, Scotland.

Research Themes

Greg's research aligns with Environment, Resources and Sustainability. Some environmental stressors require immediate solutions to prevent extinction. Emerging infectious diseases, like the Devil Facial Tumour Disease (DFTD), must be managed while infectious zoonotic diseases threaten both biodiversity and human populations. Since commencing research on devil facial tumour disease in 2006 when this disease was first identified as a serious threat to the survival of the Tasmanian devil Greg has been leading the immunology program. With limited and basic tools to analyse the immune response Greg's laboratory has been able to clearly demonstrate that the Tasmanian devil has a robust immune response. Collaboration has been an important aspect in understanding DFTD and the collaborations have resulted in significant advances including the understanding that Tasmanian devils have a limited MHC-diversity and that DFTD derived from a Schwann cell. This latter observation has led to the use of periaxin as an accurate and effective diagnostic marker of DFTD.

The current research emphasis is to understand the devil's immune response to DFTD with the ultimate objective of a vaccine. The research has now provided important advances, one of the most significant is that immunised devils can produce an immune response to DFTD. The challenge is to translate this into a vaccine that can be used to protect wild devils.

Memberships

Professional practice

  • Australasian Society for Immunology (2001 - present)
  • Australian Society for Medical Research (Board of Directors 1989-92)
  • Molecular and Experimental Society for Medical Research
  • Scientific Advisory Research Committee, Cancer Council of Tasmania
  • David Collins Leukaemia Foundation of Tasmania (1992 - present)

Administrative expertise

Prof Woods regularly reviews research grant proposals for: 

  • National Health & Medical Research Council (NHMRC)
  • David Collins Leukaemia Foundation
  • Royal Hobart Hospital Research Foundation
  • Cancer Council
  • Australian Research Council (ARC)
  • University of Tasmania Institutional Research Grants

Teaching

Immunology

Teaching expertise

Prof Woods teaches within a range of undergraduate units offered by the School of Medicine with a focus on immunology but also in medical microbiology, pathology and molecular biology. Greg's versatile teaching ability has enabled him to engage students from a range of backgrounds including science, medicine and pharmacy students. His successful use of analogies and visual aids to assist in the explanation of complex scientific ideas has made him a popular lecturer.

Teaching responsibility

Research Invitations

Prof Woods is regularly invited to present at both national and international scientific meetings.

View more on Professor Gregory Woods in WARP

Expertise

  • Cellular Immunology
  • Vaccine Research
  • Cancer Immunology
  • Comparative Immunology

Awards

  • The Australian Society for Medical Research Certificate in Recognition of Distinguished Service to Medicine, Science and Community (2015)
  • The Sherman Eureka Award for Environmental Science (as part of a team of 5, 2011) 
  •  Fellowship of the Faculty of Science, Royal College of Pathologists of Australasia (2011)

Collaboration

 Greg collaborates with groups within the University of Tasmania, Australia and overseas.

Current projects

Greg's current research emphasis is to understand the devil's immune response to DFTD with the ultimate objective of a vaccine. The research has now provided important advances, one of the most significant is that immunised devils can produce an immune response to DFTD. The challenge is to translate this into a vaccine that can be used to protect wild devils.

Fields of Research

  • Cellular Immunology (110704)
  • Veterinary Immunology (070705)
  • Tumour Immunology (110709)
  • Animal Immunology (060804)
  • Haematology (110202)
  • Oncology and Carcinogenesis (111299)
  • Epidemiology (111706)
  • Conservation and Biodiversity (050202)
  • Humoural Immunology and Immunochemistry (110705)
  • Immunology (110799)
  • Autoimmunity (110703)
  • Cancer Cell Biology (111201)
  • Medical Biochemistry and Metabolomics (110199)
  • Host-Parasite Interactions (060307)
  • Medical Biochemistry: Proteins and Peptides (incl. Medical Proteomics) (110106)
  • Veterinary Pathology (070709)
  • Respiratory Diseases (110203)
  • Zoology (060899)
  • Proteomics and Intermolecular Interactions (excl. Medical Proteomics) (060109)
  • Infectious Diseases (110309)
  • Cell Metabolism (060104)
  • Medical Genetics (excl. Cancer Genetics) (110311)
  • Biological Sciences (069999)
  • Medical Bacteriology (110801)
  • Biochemistry and Cell Biology (060199)
  • Transplantation Immunology (110708)
  • Immunogenetics (incl. Genetic Immunology) (110706)
  • Receptors and Membrane Biology (060110)
  • Cardiology (incl. Cardiovascular Diseases) (110201)
  • Microbiology (060599)
  • Cancer Therapy (excl. Chemotherapy and Radiation Therapy) (111204)
  • Population, Ecological and Evolutionary Genetics (060411)
  • Innate Immunity (110707)
  • Genomics (060408)
  • Pathology (110316)
  • Central Nervous System (110903)
  • Community Ecology (060202)
  • Medical and Health Sciences (119999)
  • Aquaculture (070401)
  • Medical Parasitology (110803)
  • Medicine, Nursing and Health Curriculum and Pedagogy (130209)
  • Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies) (110702)
  • Ecosystem Function (050102)
  • Medical Virology (110804)
  • Clinical Sciences (110399)
  • Veterinary Microbiology (excl. Virology) (070707)
  • Cellular Nervous System (110902)
  • Gene Expression (incl. Microarray and other genome-wide approaches) (060405)
  • Cancer Genetics (111203)
  • Veterinary Epidemiology (070704)
  • Veterinary Diagnosis and Diagnostics (070703)
  • Plant Physiology (060705)
  • Environmental and Occupational Health and Safety (111705)
  • Medical Biochemistry: Nucleic Acids (110105)
  • Molecular Targets (111207)
  • Toxicology (incl. Clinical Toxicology) (111506)
  • Ecology (060299)
  • Separation Science (030108)
  • Infectious Agents (060502)
  • Population Ecology (060207)
  • Veterinary Medicine (070706)
  • Peripheral Nervous System (110905)
  • Health Information Systems (incl. Surveillance) (111711)
  • Medical Microbiology (110899)
  • Physiology (060699)
  • Genome Structure and Regulation (060407)
  • Freshwater Ecology (060204)
  • Haematological Tumours (111206)
  • Veterinary Surgery (070711)
  • Animal Physiology - Systems (060603)
  • Medical Biochemistry: Lipids (110104)
  • Biological Adaptation (060303)
  • Cell Development, Proliferation and Death (060103)
  • Mycology (060505)
  • Veterinary Sciences (070799)
  • Environmental Management (050205)

Research Objectives

  • Immune System and Allergy (920108)
  • Cancer and Related Disorders (920102)
  • Flora, Fauna and Biodiversity at Regional or Larger Scales (960805)
  • Health (929999)
  • Forest and Woodlands Flora, Fauna and Biodiversity (960806)
  • Flora, Fauna and Biodiversity of environments (960899)
  • Blood Disorders (920101)
  • Expanding Knowledge in the Biological Sciences (970106)
  • Control of Pests, Diseases and Exotic Species at Regional or Larger Scales (960405)
  • Expanding Knowledge in the Environmental Sciences (970105)
  • Control of Pests, Diseases and Exotic Species (960499)
  • Skin and Related Disorders (920117)
  • Respiratory System and Diseases (incl. Asthma) (920115)
  • Nervous System and Disorders (920111)
  • Expanding Knowledge in the Agricultural and Veterinary Sciences (970107)
  • Diagnostic Methods (920203)
  • Veterinary Biological Preventatives (e.g. Vaccines) (860901)
  • Veterinary Diagnostics (860902)
  • Cardiovascular System and Diseases (920103)
  • Disease Distribution and Transmission (incl. Surveillance and Response) (920404)
  • Inherited Diseases (incl. Gene Therapy) (920110)
  • Environment (969999)
  • Preventive Medicine (920412)
  • Infectious Diseases (920109)
  • Ecosystem Assessment and Management at Regional or Larger Scales (960501)
  • Sheep - Meat (830310)
  • Clinical Health (Organs, Diseases and Abnormal Conditions) (920199)
  • Veterinary Pharmaceutical Products (860999)
  • Control of Pests, Diseases and Exotic Species in Marine Environments (960407)
  • Aquaculture Fin Fish (excl. Tuna) (830102)
  • Learner and Learning Processes (930102)
  • Diabetes (920104)
  • Expanding Knowledge in the Medical and Health Sciences (970111)
  • Neurodegenerative Disorders Related to Ageing (920112)
  • Education and Training Systems (930599)
  • Occupational Health (920505)
  • Digestive System Disorders (920105)
  • Expanding Knowledge in the Chemical Sciences (970103)
  • Coastal and Estuarine Flora, Fauna and Biodiversity (960802)
  • Skeletal System and Disorders (incl. Arthritis) (920116)

Publications

Prof Woods publishes frequently and in high quality journals including Cell, Science and Journal of Immunology.

Total publications

169

Highlighted publications

(15 outputs)
YearTypeCitationAltmetrics
2012Journal ArticleMurchison EP, Schulz-Trieglaff OB, Ning Z, Alexandrov LB, Bauer MJ, et al., 'Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer', Cell, 148, (4) pp. 780-791. ISSN 0092-8674 (2012) [Refereed Article]

DOI: 10.1016/j.cell.2011.11.065 [eCite] [Details]

Citations: Scopus - 116Web of Science - 110

Co-authors: Kreiss A

Tweet

2011Journal ArticleKreiss A, Cheng Y, Kimble F, Wells B, Donovan S, et al., 'Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity', PL o S One, 6, (7) Article e22402. ISSN 1932-6203 (2011) [Refereed Article]

DOI: 10.1371/journal.pone.0022402 [eCite] [Details]

Citations: Scopus - 27Web of Science - 24

Co-authors: Kreiss A; Kimble F; Wells B

Tweet

2011Journal ArticleMcGee HM, Malley RC, Muller HK, Woods GM, 'Neonatal exposure to UVR alters skin immune system development, and suppresses immunity in adulthood', Immunology and Cell Biology, 89, (7) pp. 767-776. ISSN 0818-9641 (2011) [Refereed Article]

DOI: 10.1038/icb.2010.170 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: McGee HM; Malley RC; Muller HK

Tweet

2011Journal ArticleTovar C, Obendorf D, Murchison EP, Papenfuss AT, Kreiss A, et al., 'Tumor-specific diagnostic marker for transmissible facial tumors of Tasmanian devils: immunohistochemistry studies', Veterinary Pathology, 48, (6) pp. 1195-1203. ISSN 1544-2217 (2011) [Refereed Article]

DOI: 10.1177/0300985811400447 [eCite] [Details]

Citations: Scopus - 23Web of Science - 22

Co-authors: Tovar C; Obendorf D; Kreiss A

Tweet

2011Journal ArticleBrown GK, Kreiss A, Lyons AB, Woods GM, 'Natural Killer Cell Mediated Cytotoxic Responses in the Tasmanian Devil', PL o S One , 6, (9) Article e24475. ISSN 1932-6203 (2011) [Refereed Article]

DOI: 10.1371/journal.pone.0024475 [eCite] [Details]

Citations: Scopus - 21Web of Science - 18

Co-authors: Brown GK; Kreiss A; Lyons AB

Tweet

2010Journal ArticleKreiss A, Tovar C, Obendorf DL, Dun K, Woods GM, 'A murine xenograft model for a transmissible cancer in Tasmanian devils', Veterinary Pathology, 48, (2) pp. 475-481. ISSN 0300-9858 (2010) [Refereed Article]

DOI: 10.1177/0300985810380398 [eCite] [Details]

Citations: Scopus - 12Web of Science - 8

Co-authors: Kreiss A; Tovar C; Obendorf DL

Tweet

2010Journal ArticleMurchison EP, Tovar C, Hsu A, Bender HS, Kheradpour P, et al., 'The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer ', Science, 327, (5961) pp. 84-87. ISSN 0036-8075 (2010) [Refereed Article]

DOI: 10.1126/science.1180616 [eCite] [Details]

Citations: Scopus - 118Web of Science - 95

Co-authors: Tovar C; Obendorf D; Blizzard CA; Kreiss A

Tweet

2009Journal ArticleKreiss A, Obendorf DL, Hemsley S, Canfield PJ, Woods GM, 'A Histological and Immunohistochemical Analysis of Lymphoid Tissues of the Tasmanian Devil', The Anatomical Record, 292, (5) pp. 611-620. ISSN 1932-8486 (2009) [Refereed Article]

DOI: 10.1002/ar.20896 [eCite] [Details]

Citations: Scopus - 15Web of Science - 15

Co-authors: Kreiss A; Obendorf DL

Tweet

2009Journal ArticleMalley RC, Muller HK, Norval M, Woods GM, 'Vitamin D3 deficiency enhances contact hypersensitivity in male but not in female mice ', Cellular Immunology, 255, (1-2) pp. 33-40. ISSN 0008-8749 (2009) [Refereed Article]

DOI: 10.1016/j.cellimm.2008.09.004 [eCite] [Details]

Citations: Scopus - 10Web of Science - 9

Co-authors: Malley RC; Muller HK

Tweet

2008Journal ArticleKreiss A, Fox N, Bergfeld J, Quinn SJ, Pyecroft S, et al., 'Assessment of cellular immune responses of health and diseased Tasmanian devils (Sarcophilus harrisii)', Developmental & Comparative Immunology, 32, (5) pp. 544-553. ISSN 0145-305X (2008) [Refereed Article]

DOI: 10.1016/j.dci.2007.09.002 [eCite] [Details]

Citations: Scopus - 28Web of Science - 25

Co-authors: Kreiss A; Quinn SJ

Tweet

2006Journal ArticleMcGee HM, Scott DK, Woods GM, 'Neonatal exposure to UV-B radiation leads to a large reduction in Langerhans cell density, but by maturity, there is an enhanced ability of dendritic cells to stimulate T cells', Immunology and Cell Biology, 84, (3) pp. 259-266. ISSN 0818-9641 (2006) [Refereed Article]

DOI: 10.1111/j.1440-1711.2006.01429.x [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: McGee HM; Scott DK

Tweet

2003Journal ArticleBellette BM, Woods GM, Wozniak TM, Doherty KV, Muller HK, 'DEC-205lo Langerinlo neonatal Langerhans' cells preferentially utilize a wortmannin-sensitive, fluid-phase pathway to internalize exogenous antigen', Immunology, 110, (4) pp. 466-473. ISSN 0019-2805 (2003) [Refereed Article]

DOI: 10.1111/j.1365-2567.2003.01759.x [eCite] [Details]

Citations: Scopus - 15Web of Science - 13

Co-authors: Bellette BM; Wozniak TM; Doherty KV; Muller HK

Tweet

2001Journal ArticleDewar AL, Doherty KV, Woods GM, Lyons AB, Muller HK, 'Acquisition of immune function during the development of the Langerhans cell network in neonatal mice', Immunology, 103, (1) pp. 61-69. ISSN 0019-2805 (2001) [Refereed Article]

DOI: 10.1046/j.1365-2567.2001.01221.x [eCite] [Details]

Citations: Scopus - 31Web of Science - 31

Co-authors: Doherty KV; Lyons AB; Muller HK

Tweet

2001Journal ArticleTrambas CM, Wang Z, Cianfriglia M, Woods GM, 'Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein', British Journal of Haematology, 114, (1) pp. 177-184. ISSN 0007-1048 (2001) [Refereed Article]

DOI: 10.1046/j.1365-2141.2001.02885.x [eCite] [Details]

Citations: Scopus - 27Web of Science - 25

Co-authors: Trambas CM

Tweet

2000Journal ArticleWoods GM, Doherty KV, Malley RC, Rist MJ, Muller HK, 'Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression', Immunology, 99, (1) pp. 16-22. ISSN 0019-2805 (2000) [Refereed Article]

DOI: 10.1046/j.1365-2567.2000.00928.x [eCite] [Details]

Citations: Scopus - 15Web of Science - 17

Co-authors: Doherty KV; Malley RC; Muller HK

Tweet

Journal Article

(64 outputs)
YearCitationAltmetrics
2017Flies AS, Blackburn NB, Lyons AB, Hayball JD, Woods GM, 'Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease', Frontiers in Immunology, 8 Article 513. ISSN 1664-3224 (2017) [Refereed Article]

DOI: 10.3389/fimmu.2017.00513 [eCite] [Details]

Co-authors: Flies AS; Blackburn NB; Lyons AB

Tweet

2017Li X, Lyons AB, Woods GM, Korner H, 'The absence of TNF permits myeloid Arginase 1 expression in experimental L. monocytogenes infection', Immunobiology, 222, (8-9) pp. 913-917. ISSN 0171-2985 (2017) [Refereed Article]

DOI: 10.1016/j.imbio.2017.05.012 [eCite] [Details]

Co-authors: Lyons AB; Korner H

Tweet

2017Tovar CD, Pye RJ, Kreiss A, Cheng Y, Brown GK, et al., 'Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils', Scientific Reports, 7 Article 43827. ISSN 2045-2322 (2017) [Refereed Article]

DOI: 10.1038/srep43827 [eCite] [Details]

Citations: Scopus - 3

Co-authors: Tovar CD; Kreiss A; Brown GK; Darby J; Malley RC; Lyons AB

Tweet

2016Brown GK, Tovar C, Cooray AA, Kreiss A, Darby J, et al., 'Mitogen activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells', Immunology and Cell Biology, 94, (7) pp. 673-679. ISSN 0818-9641 (2016) [Refereed Article]

DOI: 10.1038/icb.2016.38 [eCite] [Details]

Citations: Scopus - 6Web of Science - 4

Co-authors: Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Bettiol SS; Lyons AB

Tweet

2016Flies AS, Lyons AB, Corcoran LM, Papenfuss AT, Murphy JM, et al., 'PD-L1 is not constitutively expressed on Tasmanian devil facial tumor cells but is strongly upregulated in response to IFN-γ and can be expressed in the tumor microenvironment', Frontiers in Immunology, 7 Article 581. ISSN 1664-3224 (2016) [Refereed Article]

DOI: 10.3389/fimmu.2016.00581 [eCite] [Details]

Citations: Scopus - 3

Co-authors: Flies AS; Lyons AB

Tweet

2016Patchett AL, Darby JM, Tovar C, Lyons AB, Woods GM, 'The immunomodulatory small molecule imiquimod induces apoptosis in devil facial tumour cell lines', PL o S One, 11, (12) Article e0168068. ISSN 1932-6203 (2016) [Refereed Article]

DOI: 10.1371/journal.pone.0168068 [eCite] [Details]

Citations: Scopus - 1

Co-authors: Patchett AL; Darby JM; Tovar C; Lyons AB

Tweet

2016Pye R, Hamede R, Siddle HV, Caldwell A, Knowles GW, et al., 'Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils', Biology Letters, 12, (10) Article 20160553. ISSN 1744-9561 (2016) [Refereed Article]

DOI: 10.1098/rsbl.2016.0553 [eCite] [Details]

Citations: Web of Science - 8

Co-authors: Hamede R; Kreiss A; Jones ME; Lyons AB

Tweet

2016Atashrazm F, Lowenthal RM, Dickinson JL, Holloway AF, Woods GM, 'Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo', OncoTarget, 7, (29) pp. 46028-46041. ISSN 1949-2553 (2016) [Refereed Article]

DOI: 10.18632/oncotarget.10016 [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Co-authors: Lowenthal RM; Dickinson JL; Holloway AF

Tweet

2016Karu N, Wilson R, Hamede R, Jones M, Woods GM, et al., 'Discovery of biomarkers for Tasmanian devil cancer (DFTD) by metabolic profiling of serum', Journal of Proteome Research, 15, (10) pp. 3827-3840. ISSN 1535-3907 (2016) [Refereed Article]

DOI: 10.1021/acs.jproteome.6b00629 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Karu N; Wilson R; Hamede R; Jones M; Hilder EF; Shellie RA

Tweet

2015Atashrazm F, Lowenthal RM, Woods GM, Holloway AF, Karpiniec SS, et al., 'Fucoidan suppresses the growth of human acute promyelocytic leukemia cells in vitro and in vivo', Journal of Cellular Physiology, 231, (3) pp. 688-697. ISSN 0021-9541 (2015) [Refereed Article]

DOI: 10.1002/jcp.25119 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Lowenthal RM; Holloway AF; Dickinson JL

Tweet

2015Patchett AL, Latham R, Brettingham-Moore KH, Tovar C, Lyons AB, et al., 'Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil', Developmental and Comparative Immunology, 53 pp. 123-133. ISSN 0145-305X (2015) [Refereed Article]

DOI: 10.1016/j.dci.2015.07.003 [eCite] [Details]

Citations: Scopus - 6

Co-authors: Patchett AL; Latham R; Brettingham-Moore KH; Tovar C; Lyons AB

Tweet

2015Pye R, Woods GM, Kreiss A, 'Devil facial tumor disease', Veterinary Pathology pp. 1-11. ISSN 0300-9858 (2015) [Refereed Article]

DOI: 10.1177/0300985815616444 [eCite] [Details]

Co-authors: Kreiss A

Tweet

2015Pye RJ, Pemberton D, Tovar C, Tubio JM, Dun KA, et al., 'A second transmissible cancer in Tasmanian devils', Proceedings of the National Academy of Sciences, 113, (2) pp. 374-379. ISSN 0027-8424 (2015) [Refereed Article]

DOI: 10.1073/pnas.1519691113 [eCite] [Details]

Citations: Scopus - 24Web of Science - 24

Co-authors: Tovar C; Darby J; Kreiss A; Lyons AB

Tweet

2015Woods GM, Howson LJ, Brown GK, Tovar C, Kreiss A, et al., 'Immunology of a transmissible cancer spreading among Tasmanian devils', Journal of Immunology, 195, (1) pp. 23-29. ISSN 0022-1767 (2015) [Refereed Article]

DOI: 10.4049/jimmunol.1500131 [eCite] [Details]

Citations: Scopus - 9Web of Science - 9

Co-authors: Howson LJ; Brown GK; Tovar C; Kreiss A; Lyons AB

Tweet

2015Atashrazm F, Lowenthal RM, Woods GM, Holloway AF, Dickinson JL, 'Fucoidan and cancer: a multifunctional molecule with anti-tumor potential', Marine Drugs, 13, (4) pp. 2327-2346. ISSN 1660-3397 (2015) [Refereed Article]

DOI: 10.3390/md13042327 [eCite] [Details]

Citations: Scopus - 31Web of Science - 30

Co-authors: Lowenthal RM; Holloway AF; Dickinson JL

Tweet

2015Kreiss A, Brown GK, Tovar C, Lyons AB, Woods GM, 'Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations', Vaccine, 33, (26) pp. 3016-3025. ISSN 0264-410X (2015) [Refereed Article]

DOI: 10.1016/j.vaccine.2015.01.039 [eCite] [Details]

Citations: Scopus - 17Web of Science - 13

Co-authors: Kreiss A; Brown GK; Tovar C; Lyons AB

Tweet

2014Pinfold TL, Brown GK, Bettiol SS, Woods GM, 'Mouse Model of Devil Facial Tumour Disease Establishes That an Effective Immune Response Can be Generated Against the Cancer Cells', Frontiers in Immunology, 5 Article 251. ISSN 1664-3224 (2014) [Refereed Article]

DOI: 10.3389/fimmu.2014.00251 [eCite] [Details]

Citations: Scopus - 9Web of Science - 9

Co-authors: Pinfold TL; Brown GK; Bettiol SS

Tweet

2014Howson LJ, Morris KM, Kobayashi T, Tovar C, Kreiss A, et al., 'Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors', Anatomical Record, 297, (5) pp. 925-938. ISSN 1932-8486 (2014) [Refereed Article]

DOI: 10.1002/ar.22904 [eCite] [Details]

Citations: Scopus - 16Web of Science - 14

Co-authors: Howson LJ; Tovar C; Kreiss A

Tweet

2013Siddle HV, Kreiss A, Tovar C, Yuen CK, Cheng Y, et al., 'Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer', Proceedings of the National Academy of Sciences of the United States of America, 110, (13) pp. 5103-5108. ISSN 0027-8424 (2013) [Refereed Article]

DOI: 10.1073/pnas.1219920110 [eCite] [Details]

Citations: Scopus - 61Web of Science - 56

Co-authors: Kreiss A; Tovar C; Hamede R; Jones ME

Tweet

2013Malley RC, Muller HK, Norval M, Woods GM, 'Dietary vitamin D alters the response of the skin to UVB-irradiation depending on the genetic background of the mice', Photochemical & Photobiological Sciences, 12 pp. 536-545. ISSN 1474-9092 (2013) [Refereed Article]

DOI: 10.1039/c2pp25211b [eCite] [Details]

Citations: Scopus - 7Web of Science - 5

Co-authors: Malley RC; Muller HK

Tweet

2012Hamede R, Lachish S, Belov K, Woods G, Kreiss A, et al., 'Reduced effect of Tasmanian devil facial tumor disease at the disease front', Conservation Biology, 26, (1) pp. 124-134. ISSN 0888-8892 (2012) [Refereed Article]

DOI: 10.1111/j.1523-1739.2011.01747.x [eCite] [Details]

Citations: Scopus - 30Web of Science - 28

Co-authors: Hamede R; Lachish S; Kreiss A; Jones M; McCallum H

Tweet

2012Casey NP, Woods GM, 'Anti-PML-RARα shRNA sensitises promyelocytic leukaemia cells to all-trans retinoic acid', Journal of RNAi and Gene Silencing, 8 pp. 464-469. ISSN 1747-0854 (2012) [Refereed Article]

[eCite] [Details]

Co-authors: Casey NP

2012Murchison EP, Schulz-Trieglaff OB, Ning Z, Alexandrov LB, Bauer MJ, et al., 'Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer', Cell, 148, (4) pp. 780-791. ISSN 0092-8674 (2012) [Refereed Article]

DOI: 10.1016/j.cell.2011.11.065 [eCite] [Details]

Citations: Scopus - 116Web of Science - 110

Co-authors: Kreiss A

Tweet

2011Dorantes Aranda JJ, Waite TD, Godrant A, Rose AL, Tovar CD, et al., 'Novel application of a fish gill cell line assay to assess ichthyotoxicity of harmful marine microalgae', Harmful Algae, 10, (4) pp. 366-373. ISSN 1568-9883 (2011) [Refereed Article]

DOI: 10.1016/j.hal.2011.01.002 [eCite] [Details]

Citations: Scopus - 21Web of Science - 22

Co-authors: Dorantes Aranda JJ; Tovar CD; Hallegraeff GM

Tweet

2011Kreiss A, Cheng Y, Kimble F, Wells B, Donovan S, et al., 'Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity', PL o S One, 6, (7) Article e22402. ISSN 1932-6203 (2011) [Refereed Article]

DOI: 10.1371/journal.pone.0022402 [eCite] [Details]

Citations: Scopus - 27Web of Science - 24

Co-authors: Kreiss A; Kimble F; Wells B

Tweet

2011Brown GK, Kreiss A, Lyons AB, Woods GM, 'Natural Killer Cell Mediated Cytotoxic Responses in the Tasmanian Devil', PL o S One , 6, (9) Article e24475. ISSN 1932-6203 (2011) [Refereed Article]

DOI: 10.1371/journal.pone.0024475 [eCite] [Details]

Citations: Scopus - 21Web of Science - 18

Co-authors: Brown GK; Kreiss A; Lyons AB

Tweet

2011Miller W, Hayes VM, Ratan A, Peterson DC, Wittekindt NE, et al., 'Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil)', National Academy of Sciences of The United States of America. Proceedings, 108, (30) pp. 12348-12353. ISSN 0027-8424 (2011) [Refereed Article]

DOI: 10.1073/pnas.1102838108 [eCite] [Details]

Citations: Scopus - 91Web of Science - 88

Co-authors: Kreiss A; Jones ME

Tweet

2011Tovar C, Obendorf D, Murchison EP, Papenfuss AT, Kreiss A, et al., 'Tumor-specific diagnostic marker for transmissible facial tumors of Tasmanian devils: immunohistochemistry studies', Veterinary Pathology, 48, (6) pp. 1195-1203. ISSN 1544-2217 (2011) [Refereed Article]

DOI: 10.1177/0300985811400447 [eCite] [Details]

Citations: Scopus - 23Web of Science - 22

Co-authors: Tovar C; Obendorf D; Kreiss A

Tweet

2011McGee HM, Malley RC, Muller HK, Woods GM, 'Neonatal exposure to UVR alters skin immune system development, and suppresses immunity in adulthood', Immunology and Cell Biology, 89, (7) pp. 767-776. ISSN 0818-9641 (2011) [Refereed Article]

DOI: 10.1038/icb.2010.170 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: McGee HM; Malley RC; Muller HK

Tweet

2010Kreiss A, Tovar C, Obendorf DL, Dun K, Woods GM, 'A murine xenograft model for a transmissible cancer in Tasmanian devils', Veterinary Pathology, 48, (2) pp. 475-481. ISSN 0300-9858 (2010) [Refereed Article]

DOI: 10.1177/0300985810380398 [eCite] [Details]

Citations: Scopus - 12Web of Science - 8

Co-authors: Kreiss A; Tovar C; Obendorf DL

Tweet

2010Murchison EP, Tovar C, Hsu A, Bender HS, Kheradpour P, et al., 'The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer ', Science, 327, (5961) pp. 84-87. ISSN 0036-8075 (2010) [Refereed Article]

DOI: 10.1126/science.1180616 [eCite] [Details]

Citations: Scopus - 118Web of Science - 95

Co-authors: Tovar C; Obendorf D; Blizzard CA; Kreiss A

Tweet

2009Kreiss A, Obendorf DL, Hemsley S, Canfield PJ, Woods GM, 'A Histological and Immunohistochemical Analysis of Lymphoid Tissues of the Tasmanian Devil', The Anatomical Record, 292, (5) pp. 611-620. ISSN 1932-8486 (2009) [Refereed Article]

DOI: 10.1002/ar.20896 [eCite] [Details]

Citations: Scopus - 15Web of Science - 15

Co-authors: Kreiss A; Obendorf DL

Tweet

2009Kreiss A, Wells BB, Woods GM, 'The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against horse red blood cells ', Veterinary Immunology and Immunopathology: An International Journal of Comparative Immunology, 130, (1-2) pp. 135-137. ISSN 0165-2427 (2009) [Refereed Article]

DOI: 10.1016/j.vetimm.2009.02.003 [eCite] [Details]

Citations: Scopus - 17Web of Science - 13

Co-authors: Kreiss A; Wells BB

Tweet

2009Malley RC, Muller HK, Norval M, Woods GM, 'Vitamin D3 deficiency enhances contact hypersensitivity in male but not in female mice ', Cellular Immunology, 255, (1-2) pp. 33-40. ISSN 0008-8749 (2009) [Refereed Article]

DOI: 10.1016/j.cellimm.2008.09.004 [eCite] [Details]

Citations: Scopus - 10Web of Science - 9

Co-authors: Malley RC; Muller HK

Tweet

2009McGee HM, Dharmadasa T, Woods GM, 'Solar simulated ultraviolet radiation damages murine neonatal skin and alters Langerhans cell development, but does not induce inflammation', Photochemical & Photobiological Sciences, 8, (6) pp. 881-886. ISSN 1474-905X (2009) [Refereed Article]

DOI: 10.1039/b822591e [eCite] [Details]

Citations: Scopus - 2Web of Science - 1

Co-authors: McGee HM

Tweet

2008Kreiss A, Fox N, Bergfeld J, Quinn SJ, Pyecroft S, et al., 'Assessment of cellular immune responses of health and diseased Tasmanian devils (Sarcophilus harrisii)', Developmental & Comparative Immunology, 32, (5) pp. 544-553. ISSN 0145-305X (2008) [Refereed Article]

DOI: 10.1016/j.dci.2007.09.002 [eCite] [Details]

Citations: Scopus - 28Web of Science - 25

Co-authors: Kreiss A; Quinn SJ

Tweet

2008Muller HK, Malley RC, McGee HM, Scott DK, Wozniak T, et al., 'Effect of UV Radiation on the Neonatal Skin Immune System - Implicaions for Melanoma', Photochemistry and Photobiology, 84, (1) pp. 47-54. ISSN 0031-8655 (2008) [Refereed Article]

DOI: 10.1111/j.1751-1097.2007.00246.x [eCite] [Details]

Citations: Scopus - 14Web of Science - 14

Co-authors: Muller HK; Malley RC; McGee HM; Scott DK

Tweet

2008Stewart NJ, Bettiol SS, Kreiss A, Fox N, Woods GM, 'Mitogen-induced responses in lymphocytes from platypus, the Tasmanian devil and the eastern barred bandicoot', Australian Veterinary Journal, 86, (10) pp. 408-413. ISSN 0005-0423 (2008) [Refereed Article]

DOI: 10.1111/j.1751-0813.2008.00349.x [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Co-authors: Stewart NJ; Bettiol SS; Kreiss A

Tweet

2007Siddle HV, Kreiss A, Eldridge MDB, Noonan E, Clarke CJ, et al., 'Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial', National Academy of Sciences Proceedings, 104, (41) pp. 16221-16226. ISSN 0027-8424 (2007) [Refereed Article]

DOI: 10.1073/pnas.0704580104 [eCite] [Details]

Citations: Scopus - 168Web of Science - 159

Co-authors: Kreiss A

Tweet

2007Woods GM, Kreiss A, Bekov K, Siddle HV, Obendorf DL, et al., 'The Immune Response of the Tasmanian Devil (Sarcophilus harrisii) and Devil Facial Tumour Disease', EcoHealth, 4, (3) pp. 338-345. ISSN 1612-9202 (2007) [Refereed Article]

DOI: 10.1007/s10393-007-0117-1 [eCite] [Details]

Citations: Scopus - 47Web of Science - 37

Co-authors: Kreiss A; Obendorf DL; Muller HK

Tweet

2007Scott DK, Lord R, Muller HK, Malley RC, Woods GM, 'Proteomics identifies enhanced expression of stefin A in neonatal murine skin compared with adults: functional implications', British Journal of Dermatology, 156, (6) pp. 1156-1162. ISSN 0007-0963 (2007) [Refereed Article]

DOI: 10.1111/j.1365-2133.2007.07875.x [eCite] [Details]

Citations: Scopus - 14Web of Science - 15

Co-authors: Scott DK; Lord R; Muller HK; Malley RC

Tweet

2007Stewart NJ, Taylor BVM, Ponsonby AL, Pittas F, Van der Mei IAF, et al., 'The effect of season on cytokine expression in multiple sclerosis and healthy subjects', Journal of Neuroimmunology, 188, (1-2) pp. 181-186. ISSN 0165-5728 (2007) [Refereed Article]

DOI: 10.1016/j.jneuroim.2007.06.012 [eCite] [Details]

Citations: Scopus - 19Web of Science - 18

Co-authors: Stewart NJ; Taylor BVM; Ponsonby AL; Pittas F; Van der Mei IAF; Walters EH

Tweet

2006McGee HM, Scott DK, Woods GM, 'Neonatal exposure to UV-B radiation leads to a large reduction in Langerhans cell density, but by maturity, there is an enhanced ability of dendritic cells to stimulate T cells', Immunology and Cell Biology, 84, (3) pp. 259-266. ISSN 0818-9641 (2006) [Refereed Article]

DOI: 10.1111/j.1440-1711.2006.01429.x [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: McGee HM; Scott DK

Tweet

2005McLoone P, Woods GM, Norval M, 'Decrease in Langerhans Cells and Increase in Lymph Node Dendritic Cells Following Chronic Exposure of Mice to Suberythemal Doses of Solar Simulated Radiation', Photochemistry and Photobiology, 81, (5) pp. 1168-1173. ISSN 0031-8655 (2005) [Refereed Article]

DOI: 10.1562/2005-04-10-RA-484 [eCite] [Details]

Citations: Scopus - 22Web of Science - 20

Tweet

2005Summers C, Norval M, De las Heras M, Gonzalez L, Sharp JM, et al., 'An influx of macrophages is the predominant local immune response in ovine pulmonary adenocarcinoma', Veterinary Immunology and Immunopathology, 106, (3-4) pp. 285-294. ISSN 0165-2427 (2005) [Refereed Article]

DOI: 10.1016/j.vetimm.2005.03.006 [eCite] [Details]

Citations: Scopus - 21Web of Science - 18

Tweet

2004Brown SGA, Haas MA, Black JA, Parameswaran A, Woods GM, et al., 'In vitro testing to diagnose venom allergy and monitor immunotherapy: a placebo-controlled, crossover trial', Clinical and Experimental Immunology, 34, (5) pp. 792-800. ISSN 0954-7894 (2004) [Refereed Article]

DOI: 10.1111/j.1365-2222.2004.01949.x [eCite] [Details]

Citations: Scopus - 17Web of Science - 18

Co-authors: Haas MA; Parameswaran A

Tweet

2003Bellette BM, Woods GM, Wozniak TM, Doherty KV, Muller HK, 'DEC-205lo Langerinlo neonatal Langerhans' cells preferentially utilize a wortmannin-sensitive, fluid-phase pathway to internalize exogenous antigen', Immunology, 110, (4) pp. 466-473. ISSN 0019-2805 (2003) [Refereed Article]

DOI: 10.1111/j.1365-2567.2003.01759.x [eCite] [Details]

Citations: Scopus - 15Web of Science - 13

Co-authors: Bellette BM; Wozniak TM; Doherty KV; Muller HK

Tweet

2003Simpson CC, Woods GM, Muller HK, 'Impaired CD40-signalling in Langerhans' cells from murine neonatal draining lymph nodes: implications for neonatally induced cutaneous tolerance', Clinical and Experimental Immunology, 132, (2) pp. 201-208. ISSN 0009-9104 (2003) [Refereed Article]

DOI: 10.1046/j.1365-2249.2003.02154.x [eCite] [Details]

Citations: Scopus - 20Web of Science - 17

Co-authors: Simpson CC; Muller HK

Tweet

2003Wronski E, Woods GM, Munday BL, 'Antibody response to sheep red blood cells in platypus and echidna', Comparative Biochemistry and Physiology. Part A: Molecular and Integrative Physiology, 136, (4) pp. 957-963. ISSN 1095-6433 (2003) [Refereed Article]

DOI: 10.1016/S1095-6433(03)00325-8 [eCite] [Details]

Citations: Scopus - 10Web of Science - 8

Co-authors: Wronski E; Munday BL

Tweet

2002Hearps AC, Burrows J, Connor CE, Woods GM, Lowenthal RM, et al., 'Mitochondrial cytochrome c release precedes transmembrane depolarisation and caspase-3 activation during ceramide-induced apoptosis of Jurkat T cells', Apoptosis, 7, (5) pp. 387-394. ISSN 1360-8185 (2002) [Refereed Article]

DOI: 10.1023/A:1020034906200 [eCite] [Details]

Citations: Scopus - 37Web of Science - 34

Co-authors: Hearps AC; Burrows J; Connor CE; Lowenthal RM; Ragg SJ

Tweet

2001Connor CE, Burrows J, Hearps AC, Woods GM, Lowenthal RM, et al., 'Cell Cycle Arrest of Hematopoietic Cell Lines After Treatment With Ceramide Is Commonly Associated With Retinoblastoma Activation', Cytometry, 43, (3) pp. 164-169. ISSN 0196-4763 (2001) [Refereed Article]

DOI: 10.1002/1097-0320(20010301)43:3<164::AID-CYTO1044>3.0.CO;2-O [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: Connor CE; Burrows J; Hearps AC; Lowenthal RM; Ragg SJ

Tweet

2001Trambas CM, Wang Z, Cianfriglia M, Woods GM, 'Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein', British Journal of Haematology, 114, (1) pp. 177-184. ISSN 0007-1048 (2001) [Refereed Article]

DOI: 10.1046/j.1365-2141.2001.02885.x [eCite] [Details]

Citations: Scopus - 27Web of Science - 25

Co-authors: Trambas CM

Tweet

2001Woods GM, Chen YP, Dewar AL, Doherty KV, Toh BH, et al., 'Prevention of Autoimmunity by Induction of Cutaneous Tolerance', Cellular Immunology, 207, (1) pp. 1-5. ISSN 0008-8749 (2001) [Refereed Article]

DOI: 10.1006/cimm.2000.1733 [eCite] [Details]

Citations: Scopus - 4Web of Science - 2

Co-authors: Doherty KV; Muller HK

Tweet

2001Dewar AL, Doherty KV, Woods GM, Lyons AB, Muller HK, 'Acquisition of immune function during the development of the Langerhans cell network in neonatal mice', Immunology, 103, (1) pp. 61-69. ISSN 0019-2805 (2001) [Refereed Article]

DOI: 10.1046/j.1365-2567.2001.01221.x [eCite] [Details]

Citations: Scopus - 31Web of Science - 31

Co-authors: Doherty KV; Lyons AB; Muller HK

Tweet

2000Woods GM, Doherty KV, Malley RC, Rist MJ, Muller HK, 'Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression', Immunology, 99, (1) pp. 16-22. ISSN 0019-2805 (2000) [Refereed Article]

DOI: 10.1046/j.1365-2567.2000.00928.x [eCite] [Details]

Citations: Scopus - 15Web of Science - 17

Co-authors: Doherty KV; Malley RC; Muller HK

Tweet

1998Chen YP, Muller HK, Scarff K, Toh BH, Woods GM, 'Induction of peripheral tolerance in neonatally thymectomized mice by immunization through chemical carcinogen-altered skin', Cellular Immunology, 189, (2) pp. 99-106. ISSN 0008-8749 (1998) [Refereed Article]

DOI: 10.1006/cimm.1998.1370 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Muller HK

Tweet

1997Chen YP, Woods GM, Dandie GW, Muller HK, 'Down-regulation of an established immune response via chemical carcinogen or UVB-altered skin', Immunology and Cell Biology, 75, (3) pp. 238-244. ISSN 0818-9641 (1997) [Refereed Article]

DOI: 10.1038/icb.1997.37 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Dandie GW; Muller HK

Tweet

1997Qu MM, Muller HK, Woods GM, 'Chemical carcinogens and antigens contribute to cutaneous tumor promotion by depleting epidermal Langerhans cells', Carcinogenesis, 18, (6) pp. 1277-1279. ISSN 0143-3334 (1997) [Refereed Article]

DOI: 10.1093/carcin/18.6.1277 [eCite] [Details]

Citations: Scopus - 18Web of Science - 15

Co-authors: Qu MM; Muller HK

Tweet

1997Ragg SJ, Woods GM, Egan PJ, Dandie GW, Muller HK, 'Failure of carcinogen-altered dendritic cells to initiate T cell proliferation is associated with reduced IL-1 beta secretion', Cellular Immunology, 178, (1) pp. 17-23. ISSN 0008-8749 (1997) [Refereed Article]

DOI: 10.1006/cimm.1997.1110 [eCite] [Details]

Citations: Scopus - 8Web of Science - 7

Co-authors: Ragg SJ; Dandie GW; Muller HK

Tweet

1997Trambas CM, Muller HK, Woods GM, 'P-glycoprotein mediated multidrug resistance and its implications for pathology', Pathology, 29, (2) pp. 122-130. ISSN 0031-3025 (1997) [Refereed Article]

DOI: 10.1080/00313029700169734 [eCite] [Details]

Citations: Scopus - 16Web of Science - 16

Co-authors: Trambas CM; Muller HK

Tweet

1996Woods GM, Qu MM, Ragg SJ, Muller HK, 'Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion', Immunology, 88, (1) pp. 134-139. ISSN 0019-2805 (1996) [Refereed Article]

DOI: 10.1046/j.1365-2567.1996.d01-645.x [eCite] [Details]

Citations: Scopus - 19Web of Science - 19

Co-authors: Qu MM; Muller HK

Tweet

1995Ragg SJ, Dandie GW, Woods GM, Muller HK, 'Abrogation of afferent lymph dendritic cell function after cutaneously applied chemical carcinogens', Cellular Immunology, 162, (1) pp. 80-88. ISSN 0008-8749 (1995) [Refereed Article]

DOI: 10.1006/cimm.1995.1054 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Dandie GW; Muller HK

Tweet

1995Trambas CM, Woods GM, 'Assessment of the available techniques for analysis of P-glycoprotein mediated multidrug resistance', Australian Journal of Medical Science, 16 pp. 143-146. ISSN 1038-1643 (1995) [Refereed Article]

[eCite] [Details]

Co-authors: Trambas CM

1995Woods GM, Henderson KG, Qu MM, Muller HK, 'Processing of complex antigens and simple hapten-like molecules by epidermal Langerhans cells', Leukocyte Biology, 57, (6) pp. 891-896. ISSN 0741-5400 (1995) [Refereed Article]

PMID: 7790772 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Qu MM; Muller HK

Tweet

Chapter in Book

(3 outputs)
YearCitationAltmetrics
2013Muller HK, Woods GM, 'Ultraviolet radiation effects on the proteome of skin cells', Advances in Experimental Medicine and Biology: Radiation Proteomics, Springer, D Leszczynski (ed), Dordrecht, Netherlands, pp. 111-119. ISBN 978-940075895-7 (2013) [Research Book Chapter]

DOI: 10.1007/978-94-007-5896-4_8 [eCite] [Details]

Citations: Scopus - 9

Co-authors: Muller HK

Tweet

2004Muller HK, Halliday GM, Woods GM, 'The skin immune system and tumor immunosurveillance', The Skin Immune System, CRC Press, JD Bos (ed), Boca Raton, pp. 475-496. ISBN 0849319595 (2004) [Revised Book Chapter]

[eCite] [Details]

Co-authors: Muller HK

1997Muller HK, Halliday GM, Woods GM, 'The skin immune system and immunosurveillance', Skin immune system (SIS), CRC Press, JD Bos (ed), Florida, pp. 719. ISBN 0-8493-4016-0 (1997) [Research Book Chapter]

[eCite] [Details]

Co-authors: Muller HK

Review

(9 outputs)
YearCitationAltmetrics
2011Norval M, Woods GM, 'UV-induced immunosuppression and the efficacy of vaccination', Photochemical & Photobiological Sciences, 10, (8) pp. 1267-1274. (2011) [Review Several Works]

DOI: 10.1039/c1pp05105a [eCite] [Details]

Citations: Scopus - 17

Tweet

2010McGee HM, Woods GM, Bennett B, Chung RS, 'The two faces of metallothionein in carcinogenesis: photoprotection against UVR-induced cancer and promotion of tumour survival', Photochemical & Photobiological Sciences, 9, (4) pp. 586-596. (2010) [Substantial Review]

DOI: 10.1039/b9pp00155g [eCite] [Details]

Citations: Scopus - 20

Co-authors: McGee HM; Bennett B; Chung RS

Tweet

2008Muller HK, Malley RC, McGee HM, Scott DK, Wozniak T, et al., 'Effect of UV Radiation on the Neonatal Skin Immune System- Implications for Melanoma', Photochemistry and Photobiology, 94, (1) pp. 47-54. (2008) [Review Several Works]

DOI: 10.1111/j.1751-1097.2007.00246.x [eCite] [Details]

Co-authors: Muller HK; Malley RC; McGee HM; Scott DK

Tweet

2008Norval M, Malley RC, Woods GM, 'What's new in photoimmunology?', Photodermatology, Photoimmunology & Photomedicine, 24, (6) pp. 334-336. (2008) [Review Several Works]

[eCite] [Details]

Co-authors: Malley RC

2008Norval M, Woods GM, 'Comment on ''Hypothesis-Ultraviolet-B Irradiance and Vitamin D Reduce the Risk of Viral Infections and thus their Sequelae, Including Autoimmune Diseases and some Cancers'' by W.B. Grant, Photochem. Photobiol. (2007)', Photochemistry and Photobiology, 84 pp. 802-805. (2008) [Review Single Work]

[eCite] [Details]

2007Norval M, Malley RC, Woods GM, 'What's new in photoimmunology?', Photodermatology, Photoimmunology & Photomedicine, 23 pp. 148-151. (2007) [Review Several Works]

[eCite] [Details]

Co-authors: Malley RC

2007Norval M, Malley RC, Woods GM, 'Immune protection against photocarcinogenesis', Expert Review of Dermatology, 2, (5) pp. 1507-1515. (2007) [Substantial Review]

[eCite] [Details]

Co-authors: Malley RC

2005Norval M, Malley RC, Woods GM, 'What's new in photoimmunology', Photodermatology, Photoimmunology and Photomedicine, 21, (5) pp. 267-269. (2005) [Review Several Works]

[eCite] [Details]

Co-authors: Malley RC

2005Woods GM, Malley RC, Muller HK, 'The skin immune system and the challenge of tumour immunosurveillance', European Journal of Dermatology, 157, (2) pp. 63-69. (2005) [Substantial Review]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

Conference Publication

(89 outputs)
YearCitationAltmetrics
2017Karu N, Patchett AL, Wilson RR, Hamede Ross RK, Jones Menna, et al., 'Application of metabolomics and proteomics for biomarker discovery and development of therapies for the transmissible cancer, Tasmanian Devil Facial Tumour Disease', February 2nd-5th 2017, Lorne, VIC, pp. Page 22. (2017) [Conference Edited]

[eCite] [Details]

Co-authors: Karu N; Patchett AL; Wilson RR; Hamede Ross RK; Jones Menna; Lyons AB

2016Karu N, Wilson RR, Hamede Ross RK, Jones Menna, Woods GM, et al., 'Discovery of serum biomarkers for Tasmanian Devil cancer (DFTD)', Proceedings of The Australian & New Zealand Metabolomics Conference, 31st March - 1st April, 2016, Melbourne, Australia (2016) [Conference Extract]

[eCite] [Details]

Co-authors: Karu N; Wilson RR; Hamede Ross RK; Jones Menna; Hilder EF; Shellie RA

2015Pinfold T, Brown Gabriella, Patchett AL, Tovar CD, Bettiol SS, et al., 'Curse of the Devil: Devil Facial Tumour Disease', Australasian Cytometry Society 38th Annual Scientific Meeting, October 11-14, 2015, Perth, Australia (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Pinfold T; Brown Gabriella; Patchett AL; Tovar CD; Bettiol SS

2014Tovar C, Pye R, Kreiss A, Woods G, 'The immune response of Tasmanian devils to devil facial tumour disease cell preparations', The 5th Australasian Vaccines & Immunotherapeutics Development Meeting, 7-9 May, Melbourne, Australia (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Tovar C; Kreiss A

2013Pinfold T, Brown Gabriella, Woods GM, 'Cancer from hell: Devil Facial Tumour Disease', 15th International Congress of Immunology, 22-27 August, 2013, Milan, Italy (2013) [Conference Extract]

[eCite] [Details]

Co-authors: Pinfold T; Brown Gabriella

2010Malley RC, Muller HK, Norval M, Woods GM, 'Vitamin D3, the skin immune system and cutaneous carcinogenesis', Report of the National Institute of Water and Atmospheric Research (NIWA) UV Workshop, 7-9 May, Queenstown, New Zealand, pp. 51. (2010) [Non Refereed Conference Paper]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

2010Malley RC, Muller HK, Woods GM, 'Vitamin D3 influences skin draining lymph node dendritic cells in neonatal male mice', National Health and Medical Research Congress, Melbourne, pp. 398. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

2009Kreiss A, Tovar C, Woods GM, 'Immunisation of Tasmanian devils (Sarcophilus harrisii) against Devil Facial Tumour Disease Tumour Cells', The 5th International Veterinary Vaccines and Diagnostics Conference, 19-23 July, Madison, USA (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Kreiss A; Tovar C

2009Malley RC, Muller HK, Woods GM, 'Dietary vitamin D3 protects against UVB-induced immunosuppression in C57BL/6, but not BALB/c mice', MEPSA Conference, Sydney (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

2009Kreiss A, Woods GM, 'Immunisation of Tasmanian Devils against Devil Facial Tumour Disease Tumour Cells', 58th Annual International Conference of the Wildlife Disease Association, August 2-7, Blaine, Washington (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Kreiss A

2008Malley RC, Muller HK, Woods GM, 'Vitamin D3 nutrition influences regulatory T cell induction in neonatal tolerance and adult immunity', MEPSA Conference, December, Brisbane (2008) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

2007Bettiol SS, Ragg SJ, Woods GM, 'Catering to Student Demand: Bridging the Gap between Academics and Practicing Health Professionals', Improving University Teaching, Jaen, Spain (2007) [Conference Extract]

[eCite] [Details]

Co-authors: Bettiol SS; Ragg SJ

2007Kreiss A, Woods GM, 'The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against two cellular antigens', Proceedings of the International Congress of Immunology, Rio de Janeiro, Brazil (2007) [Conference Extract]

[eCite] [Details]

Co-authors: Kreiss A

2007Malley RC, Muller HK, Woods GM, 'Dietary vitamin D3 influences UVB induced DNA damage and immunosuppression', Mutagenesis and Experimental Pathology of Australasia Conference, Hobart (2007) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

2007Malley RC, Muller HK, Woods GM, 'Vitamin D promotes neonatal tolerance induction to contact sensitisers', Australasian Society for Immunology Meeting, Sydney (2007) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

2007Kreiss A, Woods GM, 'The immune responses of the Tasmanian devil (Sarcophilus harrisii) and the Devil Facial Tumour Disease', Proceedings of the 8th International Veterinary Immunology Symposium, 15-19 August, Ouro Preto, Brazil (2007) [Conference Extract]

[eCite] [Details]

Co-authors: Kreiss A

2007Kreiss A, Woods GM, 'The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against two cellular antigens', 37th Annual Scientific Meeting for the Australasian Society for Immunology, Manly, Sydney (2007) [Conference Extract]

[eCite] [Details]

Co-authors: Kreiss A

2006Kreiss A, Clarke C, Woods GM, 'Impaired allogeneic recognition may account for establishment of Devi Facial Tumour disease cells in Tasmanian devils', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 378. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Kreiss A; Clarke C

2006Kreiss A, Woods GM, 'Mitogen induced lymphocyte proliferation and mixed lymphocyte reaction in Tasmanian devils (Sarcophilus harrisii)', Proceedings of the Australasian Society for Immunology, December, 2006, Auckland, New Zealand (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Kreiss A

2006Malley RC, Muller HK, Woods GM, 'Modification of skin immune system function by dietary vitamin D3 is influenced by age and gender', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 218. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

2006McGee HM, Woods GM, 'Neonatal exposure to solar simulated radiation alters development of skin immune system, resulting in long-term changes in lymph node cell populations', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 274. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: McGee HM

2006Woods GM, Kreiss A, 'Immune response of the Tasmanian devil', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 304. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Kreiss A

2006Dharmadasa T, Malley RC, Muller HK, Woods GM, 'Dietary Vitamin D3 deficiency alters skin UVB-induced DNA damage in neonatal mice', Proceedings of the Australian Health and Medical Research Congress 2006, November, 2006, Melbourne, Victoria, pp. 466. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

2006Wright N, Wotherspoon SJ, Woods GM, Lowenthal RM, Ragg S, 'Reducing the toxicity of autologous stem cell transplants', Annual Scientific Meeting Handbook, 15-18 October 2006, Hobart, pp. 95. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Wotherspoon SJ; Lowenthal RM

2005Kalodimos G, Muller HK, Feltis BN, Woods GM, 'The role of mast cells in neonatally induced suppression', Tissue Antigens, November, 2005, Melbourne, Victoria, pp. 458. ISSN 0001-2815 (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Kalodimos G; Muller HK; Feltis BN

2005McGee HM, Woods GM, 'Neonatal Langerhans cell are more susceptible to ultraviolet radiation than adult Langerhans cells', Tissue Antigens, November, 2005, Melbourne, Victoria, pp. 491. ISSN 0001-2815 (2005) [Conference Extract]

[eCite] [Details]

Co-authors: McGee HM

2005Scott DK, Lord RJ, Muller HK, Woods GM, 'Proteomics identifies enhanced expression of stefinA in neonatal murine skin compared to adult skin: Functional implications', Tissue Antigens, November, 2005, Melbourne, Victoria, pp. 537. ISSN 0001-2815 (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Scott DK; Lord RJ; Muller HK

2005Woods GM, Bellette BM, Kalodimos G, Muller HK, 'Poverty of inflammation in neonatal skin', Inflammation Research, August, 2005, Melbourne, Victoria, pp. S166. (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Bellette BM; Kalodimos G; Muller HK

2005Woods GM, Bellette BM, Scott DK, Muller HK, 'Neonatal Langerhans cells process, but do not effectively present, antigen resulting in impaired immunity', Abstracts of the 9th International workshop on Langerhans cells, September, 2005, Medeira, Portugal, pp. 90-91. (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Bellette BM; Scott DK; Muller HK

2005Malley RC, Muller HK, Woods GM, 'Vitamin D deficiency alters the contact sensitivity response in BALB/c mice', Tissue Antigens, November, 2005, Melbourne, Victoria, pp. 486. ISSN 0001-2815 (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

2001Woods GM, 'Session Co-chair', Proceedings of the 31st Annual Meeting of the Australasian Society for Immunology, 2-6 December, Canberra, pp. 77-78. (2001) [Chair National Conference]

[eCite] [Details]

2001Connor C, Burrows J, Woods GM, Ragg SJ, 'Ceramide activates the retinoblastoma protein via two independent mechanisms and induces maturation of human leukaemia cells', Abstract, 8-11th February 2001, Lorne Victoria (2001) [Conference Extract]

[eCite] [Details]

Co-authors: Connor C; Burrows J; Ragg SJ

2001Jongbloed SL, Trambas CM, Woods GM, 'Non-apoptotic activation induced cell death of NK cells', Scandinavian Journal of Immunology, 22-27 July, Stockholm, Sweden, pp. Thu-17. ISSN 0301-6323 (2001) [Conference Extract]

[eCite] [Details]

Co-authors: Jongbloed SL; Trambas CM

2001Bellette BM, Woods GM, Muller HK, 'Altered kinetics of antigen uptake by neonatal Langerhans cell: Implications for tolerance induction', Natural Products Which Modulate Tissue Repair, 29-30 November, Sydney, pp. 12. (2001) [Conference Extract]

[eCite] [Details]

Co-authors: Bellette BM; Muller HK

2001Ng W, Doherty KV, Muller HK, Woods GM, 'Antigen induced maturation of neonatal Langerhans cells', Scandinavian Journal of Immunology, 22-27 July, Stockholm, Sweden, pp. Thu - 30. ISSN 0301-6323 (2001) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

2001Trambas CM, Wang Z, Woods GM, 'Expression of mini-P-glycoprotein but not classical P-glycoprotein in human natural killer cells', Scandinavian Journal of Immunology, 22-27 July, Stockholm, Sweden, pp. Wed - 78. ISSN 0301-6323 (2001) [Conference Extract]

[eCite] [Details]

Co-authors: Trambas CM

2001Jongbloed SL, Trambas CM, Woods GM, 'Non-apoptotic death of activated NK cells', Proceedings of the 31st Annual Meeting of the Australasian Society for Immunology, 2-6 December, Canberra, pp. 79. (2001) [Conference Extract]

[eCite] [Details]

Co-authors: Jongbloed SL; Trambas CM

2001Wozniak TM, Woods GM, Muller HK, 'Delayed immune response during neonatal development: A link between phenotype and function', Proceedings of the 31st Annual Meeting of the Australasian Society for Immunology, 2-6 December, Canberra, pp. 51. (2001) [Conference Extract]

[eCite] [Details]

Co-authors: Wozniak TM; Muller HK

2001Muller HK, Doherty KV, Dewar AL, Chen YP, Toh BH, et al., 'Immature Langerhans cells: Central role in tolerance induction in carcinogen-treated and neonatal skin', Journal of Investigative Dermatology, 7-9 September, Stresa, Italy, pp. 1010. ISSN 0022-202X (2001) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK; Doherty KV

2000Doherty KV, Dewar AL, Woods GM, Muller HK, 'Are Recent Cell Immigrants to Adult Skin the Functional Correlate of Neonatal Cells?', 6th International Symposium on Dendritic Cells, 26 May - 1 June, Port Douglas, pp. 126. (2000) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

2000Marsden VS, Woods GM, Trambas CM, Muller HK, 'Expression of P-glycoprotein by Dendritic Cells is not Required for Function', 6th International Symposium on Dendritic Cells, 26 May - 1 June, Port Douglas, pp. 74. (2000) [Conference Extract]

[eCite] [Details]

Co-authors: Trambas CM; Muller HK

2000Trambas CM, Wang Z, Woods GM, 'Expression if Small Molecular Weight P-glycoprotein in NK Cells and Association with Restricted Transport Function', The 18th Natural Killer Cell Workshop, 5-9 May, 2000, Marseille, France, pp. IX-12. (2000) [Conference Extract]

[eCite] [Details]

Co-authors: Trambas CM

2000Woods GM, Chen YP, Doherty KV, Toh BH, Muller HK, 'Protection Against Autoimmune Disease by Immunisation Through Skin Containing Immature Langerhans Cells', 6th International Symposium on Dendritic Cells, 26 May - 1 June, Port Douglas, pp. 127. (2000) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1999Bellette BM, Doherty KV, Woods GM, Muller HK, 'Modulation of Langerhans cell function: A role for antigen dose', 38th National Scientific Conference of the Australian Society for Medical Research, 27-29/11/1999, Leura, NSW, pp. oral 6-1. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: Bellette BM; Doherty KV; Muller HK

1999Connor CE, Woods GM, Lowenthal RM, Ragg SJ, 'Induction of p121CIP1 expression and retinoblastoma activation by ceramide in leukaemia cells', Signalling for life and death: cytometry in analysis and modelling of cell signalling, 18-21/7/1999, Hamilton Island, Australia, pp. 63. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: Connor CE; Lowenthal RM; Ragg SJ

1999Connor CE, Woods GM, Lowenthal RM, Ragg SJ, 'Induction of p121CIP1 expression and retinoblastoma activation by ceramide in leukaemia cells', Signalling for life and death: cytometry in analysis and modelling of cell signalling, 18-21/7/1999, Hamilton Island, Australia, pp. 63. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: Connor CE; Lowenthal RM; Ragg SJ

1999Dewar AL, Doherty KV, Woods GM, Muller HK, 'Neonatal Langerhans cells and maturation of antigen presenting cells', 6th International Workshop on Langerhans cells, 8-10/10/1999, New York, USA, pp. 45. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1999Dewar AL, Doherty KV, Woods GM, Muller HK, 'Maturation of antigen presenting cell function in neonatal Langerhans cells', 1st Annual Meeting of the Haematology Society of Australia and New Zealand, 17-10/10/1999, Hobart, Tasmania, pp. 182. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1999Doherty KV, Becker HE, Trambas CM, Woods GM, Muller HK, 'Fluorescent probes lack specificity for functional P-glycoprotein detection', 38th National Scientific Conference of the Australian Society for Medical Research, 27-29/11/1999, Leura, NSW, pp. poster 1-9. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Trambas CM; Muller HK

1999Doherty KV, Dewar AL, Woods GM, Muller HK, 'Carcinogen induced Langerhans cells: the functional correlate of neonatal Langerhans cells?', 38th National Scientific Conference of the Australian Society for Medical Research, 27-29/11/1999, Leura, NSW, pp. poster 1-8. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1999Marsden VS, Trambas CM, Woods GM, Muller HK, 'Is P-glycoprotein involved in Langerhans cell function?', 38th National Scientific Conference of the Australian Society for Medical Research, 27-29/11/1999, Leura, NSW, pp. poster 1-10. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: Trambas CM; Muller HK

1999Woods GM, Chen YP, Doherty KV, Dewar AL, Toh BH, et al., 'Modification of dendritic cell function -Implications for autoimmunity', 1st Annual Meeting of the Haematology Society of Australia and New Zealand, 17-10/10/1999, Hobart, Tasmania, pp. 169. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1998Trambas CM, Woods GM, 'Regulation and function of P-glycoprotein in human natural killer cells', 28th Annual meeting of the Australasian Society for Immunology, 29 November - 4 December, Melbourne, Victoria, pp. symposium 19-61. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Trambas CM

1998Dewar AL, Doherty KV, Woods GM, Muller HK, 'Neonatal Langerhans cells are defective in uptake and presentation of antigen and induce immunosuppression', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 70. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1998Doherty KV, Woods GM, Muller HK, 'Recent immigrants to the skin present antigen following carcinogen treatment', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 56. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1998Doherty KV, Woods GM, Muller HK, 'After cutaneous DMBA treatment, newly arrived Langerhans cells induce antigen specific immunosuppression', Journal of Leukocyte Biology, September 23-28, Pittsburgh, USA, pp. 90. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1998Muller HK, Malley RC, Woods GM, 'Alterations of Langerhans cell function during the early stages of cutaneous carcinogenesis confers immunosuppression rather than immunity', Journal of Investigative Dermatology, 7-10 May, Cologne, Germany, pp. 565. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK; Malley RC

1998Rist MJ, Woods GM, Muller HK, 'Characterisation of carcinogen induced regulatory effector cells', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 70. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

1998Rist MJ, Woods GM, Muller HK, 'Analysis of migrating epidermal dendritic cells in carcinogen and contact sensitiser induced immunosuppression', 28th Annual meeting of the Australasian Society for Immunology, 29 November - 4 December, Melbourne, Victoria, pp. poster 5-60. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

1998Rist MJ, Woods GM, Muller HK, 'Phenotypic analysis of migrating epidermal dendritic cells in carcinogen and contact sensitiser induced immunosuppression', Journal of Leukocyte Biology, September 23-28, Pittsburgh, USA, pp. 90. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

1998Trambas CM, Woods GM, 'Detection of a novel P-glycoprotein conformation in drug-sensitive cells', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 43. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Trambas CM

1998Doherty KV, Woods GM, Muller HK, 'Presentation by antigen following topical DMBA treatment is mediated by newly arrived Langerhans cells', 28th Annual meeting of the Australasian Society for Immunology, 29 November - 4 December, Melbourne, Victoria, pp. poster 5-1. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1998Woods GM, 'Immunology/Inflammation', 37th National Scientific Conference of the Australian Society for Immunology, 22-25 November, Hobart, Tasmania, pp. Oral 13. (1998) [Chair National Conference]

[eCite] [Details]

1998Woods GM, Chen YP, Doherty KV, Toh BH, Muller HK, 'Modifying skin immunity', 37th Annual Meeting of the Australian Society for Medical Research, 22-25 November, Hobart, Tasmania, pp. 34. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1998Dewar AL, Doherty KV, Woods GM, Muller HK, 'Neonatal Langerhans cells induce antigen specific suppression', 28th Annual meeting of the Australasian Society for Immunology, 29 November - 4 December, Melbourne, Victoria, pp. poster 5-10. (1998) [Conference Extract]

[eCite] [Details]

Co-authors: Doherty KV; Muller HK

1997Malley RC, Muller HK, Woods GM, 'Reduced dendritic cell function during the early stages of chemical carcinogenesis', 27th Annual Meeting of the Australasian Society for Immunology, Perth, pp. 68. (1997) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

1997Malley RC, Woods GM, Muller HK, 'Langerhans cell function during the early stages of carcinogenesis', 5th International Workshop on Langerhans cells, Salzburg, Vienna, pp. 268. (1997) [Conference Extract]

[eCite] [Details]

Co-authors: Malley RC; Muller HK

1997Rist MJ, Woods GM, Muller HK, 'Antigen specific suppression in cutaneous carcinogenesis', Joint Meeting of the Australian and New Zealand Environmental Mutagen Society and the Australasian Society for Experimental Pathology, Mt. Buller, Victoria, pp. 21. (1997) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

1997Trambas CM, Woods GM, 'Selective involvement of P-glycoprotein in the granule pathway of cell mediated cytotoxicity', 27th Annual Meeting of the Australasian Society for Immunology, Perth, pp. 91. (1997) [Conference Extract]

[eCite] [Details]

Co-authors: Trambas CM

1997Woods GM, 'Alterations of Langerhans cell function during the early stages of cutaneous carcinogenesis', 27th Annual Meeting of the Australasian Society for Immunology, Perth, pp. 37. (1997) [Conference Extract]

[eCite] [Details]

1996Chen YP, Woods GM, Scarff K, Toh BH, Muller HK, 'Cutaneous tolerance -- A potential strategy for treatment of autoimmune disease', Federation of Immunological Societies of Asia-Oceania, Adelaide, pp. 104. (1996) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

1996Muller HK, Chen YP, Dandie GW, Woods GM, 'Downregulation of immune responses by modified dendritic cells', Proceedings of the Australasian Society for Experimental Pathology Conference, Sydney, pp. 23. (1996) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK; Dandie GW

1996Muller HK, Dandie GW, Woods GM, 'UV-B-induced immune suppression: implications for infection', The health consequences of ozone depletion, Hobart, pp. 225-229. (1996) [Non Refereed Conference Paper]

[eCite] [Details]

Co-authors: Muller HK; Dandie GW

1996Woods GM, Qu MM, Muller HK, 'Langerhans cell depletion is a key component of cutaneous tumour promotion', Federation of Immunological Societies of Asia-Oceania, Adelaide, pp. 69. (1996) [Conference Extract]

[eCite] [Details]

Co-authors: Qu MM; Muller HK

1995Ragg SJ, Woods GM, Muller HK, 'Failure of carcinogen-altered dendritic cells to initiate T cell proliferation is associated with reduced IL-1B secretion', 9th International Congress of Immunology, San Francisco, USA, pp. 64. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

1995Chen YP, Woods GM, Dandie GW, Muller HK, 'Downregulation of an established immune response - a possible tactic for the treatment of autoimmune disease', Australasian Society for Immunology - Annual Conference, Gold Coast, Queensland, pp. 111. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Dandie GW; Muller HK

1995Field CM, Burges-Watson IP, Quinn D, Woods GM, Muller HK, 'Does combat-related post-traumatic stress disorder have a unique effect on immune responses?', Australasian Society for Immunology Annual Scientific Meeting, Gold Coast, Queensland, pp. 125. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Quinn D; Muller HK

1995Gabrilovich DI, Patterson S, Harvey JJ, Woods GM, Elsley W, et al., 'Defects in the function of dendritic cells in murine retroviral infection', Dendritic cells in fundamental and clinical immunology, Annecy, France, pp. 469-472. (1995) [Non Refereed Conference Paper]

[eCite] [Details]

1995Muller HK, Ragg SJ, Chilcott AR, Grzegorczck AD, Dandie GW, et al., 'Langerhans cell function during carcinogen induced immunosuppression', Langerhans Cells, 4th International Workshop, Scheveningen, The Netherlands, pp. 862. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK; Chilcott AR; Dandie GW

1995Muller HK, Ragg SJ, Dandie GW, Woods GM, 'Langerhans cell function during carcinogenesis', Australasian Society for Experimental Pathology, Auckland, New Zealand, pp. 18. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK; Dandie GW

1995Ragg SJ, Dandie GW, Woods GM, Muller HK, 'Dendritic cells migrating from carcinogen-treated skin have reduced antigen-presenting function', Dendritic cells in fundamental and clinical immunology, Annecy, France, pp. 237-241. (1995) [Non Refereed Conference Paper]

[eCite] [Details]

Co-authors: Dandie GW; Muller HK

1995Chen YP, Woods GM, Scarff K, Toh BH, Muller HK, 'Antigen presentation by modified dendritic cells as a strategy to down regulate autoimmunity', 4th International Workshop on the Molecular and Cell Biology of Autoantibodies and Autoimmunity, Melbourne, pp. 76. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

1995Rist MJ, Woods GM, Muller HK, 'Phenotype of migrating murine antigen presenting cells in cutaneous carcinogenesis', Australasian Society for Immunology Annual Scientific Meeting, Gold Coast, Queensland, pp. 55. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

1995Rist MJ, Woods GM, Muller HK, 'Phenotypic analysis of migrating murine antigen presenting cells in a model of cutaneous carcinogenesis', Australasian Flow Cytometry Group 18th Annual Meeting, Hobart, Tasmania, pp. no number. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

1995Trambas CM, Muller HK, Woods GM, 'Multidrug resistance and resistance to natural killer cells', 9th International Congress of Immunology, San Francisco, USA, pp. 483. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Trambas CM; Muller HK

1995Trambas CM, Woods GM, 'P-Glycoprotein is involved in the secretion of cytotoxic factors during the terminal stage of natural killer cell cytotoxicity', Australasian Society for Immunology Annual Scientific Meeting, Gold Coast, Queensland, pp. 59. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Trambas CM

1995Woods GM, 'Apoptosis, Cancer and Oncogenes', Medical Oncology Group of Australia inc. Mid Year Meeting, Cradle Mountain, Tasmania, pp. 24. (1995) [Conference Extract]

[eCite] [Details]

1995Woods GM, Gabrilovich DI, Elsley W, English N, Knight S, 'Dendritic cells, apoptosis and murine retrovirus', Dendritic cells in fundamental and clinical immunology, Annecy, France, pp. 493-496. (1995) [Non Refereed Conference Paper]

[eCite] [Details]

1995Woods GM, Grzegorczck AD, Field CM, Ragg SJ, Muller HK, 'Analysis of dendritic cells during carcinogen induced immunosuppression', 9th International Congress of Immunology, San Francisco, USA, pp. 410. (1995) [Conference Extract]

[eCite] [Details]

Co-authors: Muller HK

Other Public Output

(4 outputs)
YearCitationAltmetrics
2016Flies AS, Woods GM, 'Deadly disease can 'hide' from a Tasmanian devil's immune system', The Conversation (2016) [Magazine Article]

[eCite] [Details]

Co-authors: Flies AS

2014Pinfold T, Woods GM, Bettiol SS, Brown Gabriella, 'The Devil's Details', The Scientist, online, 1 November, 2014 (2014) [Magazine Article]

[eCite] [Details]

Co-authors: Pinfold T; Bettiol SS; Brown Gabriella

1999Woods GM, 'Uni work may help beat diseases', Mercury, Hobart, Tasmania, 6 September 1999 (1999) [Newspaper Article]

[eCite] [Details]

1999Woods GM, 'Cash injection aids research', Australian, Melbourne, Victoria, 15/12/99 (1999) [Newspaper Article]

[eCite] [Details]

Grants & Funding

The high quality  and valuable contribution of Prof Wood's research continues to be recognised through ongoing support. In recent years his pivotal role in the Tasmanian Devil Facial Tumour Disease (DFTD) research programme has attracted funding from both the ARC and a number of smaller funding bodies.

Funding Summary

Number of grants

122

Total funding

$6,188,582

Projects

A live-attenuated vaccine (DFT-Off) to promote long-term anti-DFTD immunity (2017 - 2018)$35,000
Description
We have developed a system that allows us to switch genes on/off in devil facial tumour (DFT) cells. The DFT-Off cells have the potential to be used as a live-attenuated vaccine, which generally perform better than killed vaccines, that provides long-term protection against both forms of DFT disease (DFTD).
Funding
University of Tasmania Foundation Inc ($35,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Flies AS; Woods GM; Lyons AB
Period
2017 - 2018
Distribution, prevalence and epidemiology of DFTD and DFT2 on the d Entrecasteaux channel area (2017)$31,130
Description
Two different transmissible cancers (DFTD and DFT2) are present in south-eastern Tasmania. This study will assess the distribution, prevalence, infection dynamics and survival after infection in both cancers. This information will create a baseline dataset for evaluating the threat of DFT2 and its possible interactions and selective processes with DFTD.
Funding
University of Tasmania Foundation Inc ($31,130)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Hamede Ross RK; Jones ME; Woods GM; Darby JM
Year
2017
CRISPR screen to identify key genes driving DFTD (2017)$33,500
Description
We will apply leading genomic techniques to identify the genes essential for the proliferation of the Tasmanian Devil Facial Tumour. By systematically disrupting each gene in the cancer, we will also identify genes which help the tumour evade the immune system.
Funding
University of Tasmania Foundation Inc ($33,500)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Hewitt A; Liu G; Woods GM; Flies AS; Cook AL
Year
2017
Evaluating the benefits in Tasmanian devils of immune responses to transmissible cancer (2017)$25,000
Description
A one year field and laboratory study to further our work on the evolution of resistance and tolerance in Tasmanian devils to facial tumor disease and to advance knowledge of immunology of devils for vaccine research. This work is a collaboration between the School of Biological Sciences and the Menzies Institute for Medical Research.
Funding
University of Tasmania Foundation Inc ($25,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Jones ME; Hamede Ross RK; Carver SS; Woods GM
Year
2017
Developing DFTD vaccination approaches to favour cell mediated anti-tumour immunity (2017 - 2018)$32,304
Description
To successfully vaccinate Tasmanian devils against DFTD, a particular form of response known as cell mediated immunity is needed. This project will test the ability of two distinct approaches to enhance cell mediated immune responses against DFTD.
Funding
University of Tasmania Foundation Inc ($32,304)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Lyons AB; Patchett AL; Woods GM
Period
2017 - 2018
Proteomics for Tasmanian devils: a DFTD pre-clinical test (2017)$15,000
Description
Proteins within the circulatory system offer insight into the pathophysiology of an individual, and protein biomarkers are frequently the basis for clinical diagnostic tests. This project will use proteomics to compare serum from non-infected and DFTD-infected Tasmanian devils to identify a DFTD-specific protein signature that could be used to develop a diagnostic test for early detection of DFTD.
Funding
University of Tasmania Foundation Inc ($15,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Wilson RR; Hamede Ross RK; Woods GM
Year
2017
Evaluation of the role natural killer (NK) cells in protection against DFTD (2017)$26,487
Description
Natural Killer (NK) cells have a major role in the first line of defence against cancer. This project will investigate the presence and function of NK cells in the Tasmanian devil. The ultimate goal is to determine if NK cells are involved in the rejection of DFTD tumours.
Funding
University of Tasmania Foundation Inc ($26,487)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Woods GM; Lyons AB; Flies AS
Year
2017
Deciphering the cellular origin of the second Devil Facial Tumour Disease (DFT2) (2017)$34,165
Description
We have established a multifaceted study to understand the cellular origin of DFT2 by producing large datasets with gene and protein profiles for DFT1 and DFT2. This proposal will use bioinformatics tools for the analysis of these data and the interpretation of the results in order to promote a more comprehensive understanding of the biology of DFTD
Funding
University of Tasmania Foundation Inc ($34,165)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Woods GM; Tovar Lopez CD; Wilson RA; McKay M; Papenfuss A
Year
2017
Tasmanian Devil Vaccine (2016)$179,000
Description
To develop a vaccine against Devil Facial Tumour Disease
Funding
University of Tasmania Foundation Inc ($179,000)
Scheme
Donation - Individual
Administered By
University of Tasmania
Research Team
Woods GM; Lyons AB
Year
2016
Translating human cancer immunotherapy techniques for use in pets and Tasmanian devils (2016 - 2017)$140,000
Description
Immunotherapeutics targeting PD-1 and CTLA4 have shown unprecedented success in treating human cancers. Surprisingly, little is known to date on the potential for translating these human immunotherapy approaches into cancer treatments for veterinary medicine. The Tasmanian devil facial tumours (DFTs) and canine transmissible venereal tumour (CTVT) provide unique opportunities to assess immunotherapeutic treatment regimens for two naturally occurring tumours. Our ongoing work on the DFT has already developed ten anti-PD-1, nine anti-PD-L1 (aka B7-H1), and four anti-CTLA4 monoclonal antibodies (mAbs) that are highly specific for devil proteins. We have developed a system that can be used to rapidly generate new mAbs against additional target proteins. Importantly, this system can be readily applied to the production of antibodies that target proteins in other species. We have already begun cloning target genes in dogs, and will begin production of recombinant dog proteins, cell lines, and mAbs in 2016. The devil immunology group will develop dog-specific mAbs, and perform in vitro testing functional testing of the mAbs. The first batch of antibodies for PETization will be delivered to Nexvet in January, 2017. The initial functional testing of the antibodies performed by the devil immunology team will generate vital preliminary data to support planned ARC Linkage Project application in 2016-2017 in order to leverage funds for ongoing collaborative research. Establishing a solid connection between Nexvet and the devil immunology team prior to submission of the ARC Linkage Project application will greatly increase the probability receiving a Linkage Project award and leveraging funds. This research could help save an iconic Australian animal from extinction, develop immunotherapeutics to improve and extend the lives of pets around the world, and help to drive an emerging market for pharmaceuticals for pets.
Funding
Department of Industry and Science ($50,000); Nexvet Australia Pty Ltd ($90,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Flies AS; Woods GM; Lyons AB; Hayball J
Period
2016 - 2017
Improving the DFTD vaccine by targeting key immune signalling molecules (2016)$35,000
Description
We have discovered that our current vaccine approach of using interferon-gamma (IFNg) to make the DFTD tumour cells visible to the devil immune system also induces upregulation of molecules that inhibit anti-tumour immune responses. We are now modifying the vaccine to counteract the effects of the inhibitory molecules.
Funding
University of Tasmania Foundation Inc ($35,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Flies AS; Woods GM; Lyons AB
Year
2016
Detection of activated Tasmanian devil cytotoxic lymphocytes by a rapid RNA detection assay (2016)$34,999
Description
Monitoring the immune response of vaccinated Tasmanian devils requires analysis of cell mediated immunity .The current assays we use demonstrate killing of DFTD cells but fail to reveal cytotoxic cell activation and themeans of cell death. We plan incorporate a new assay that employs fluorescent in situ hybridisation andbranched DNA amplification technique for simultaneous measurement of RNA transcripts in single cells usingflow cytometry. The advantages of the proposed assay is that it provides a rapid and biologically relevantanalysis of fresh blood samples taken from Tasmanian devils and measures the activity level of these cellsequivalent to when they were in circulation. This will determine if cytotoxic cells are activated to induce targetcell death. We will be able to analyse key gene expression markers for activation such as IFN-gamma andLAMP-I.
Funding
University of Tasmania Foundation Inc ($34,999)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Pinfold T; Bettiol SS; Woods GM; Lyons AB
Year
2016
Immunological approach to protect Tasmanian devils against devil facial tumour disease (2015 - 2016)$29,000
Description
This project is aimed at refining our immunisation procedure that stimulates the devil's immune system to recognise and kill DFTD tumour cells.
Funding
University of Tasmania Foundation Inc ($29,000)
Scheme
Donation - Individual
Administered By
University of Tasmania
Research Team
Woods GM; Kreiss A
Period
2015 - 2016
Vaccination of Tasmanian devils to induce a memory response against DFTD (2015)$29,000
Description
This project will test whether a newly developed vaccination strategy will protect the Tasmanian devil from acquiring the deadly Devil Facial Tumour Disease (DFTD). The vaccination consists of a series of booster immunisations, similar to the chicken pox vaccine, that aims to prime the devil's memory immune response to recognise and eradicate invading tumour cells. The project will provide valuable knowledge as to whether the vaccine and long-term booster injection will protect devils from DFTD. Results will be communicated with the scientific and public community by scientific presentations, conference presentations, community presentations and media releases.
Funding
University of Tasmania Foundation Inc ($29,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Kreiss A; Woods GM; Pye Ruth
Year
2015
Up-regulating MHC expression of DFTD cells in vivo by treating established tumours with imiquimod (2015)$28,000
Description
DFTD cells avoid immune recognition and destruction because they turn off important genes. Recent research discovered that imiquimod, a drug used to treat skin cancer, can turn on these genes. This project will determine if imiquimod makes DFTD cells visible to the Tasmanian devil's immune system, thereby inducing an immune response.
Funding
University of Tasmania Foundation Inc ($28,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Pinfold T; Bettiol SS; Woods GM
Year
2015
Can DFTD cells be made visible to the Tasmanian devil immune system? (2014)$28,000
Description
DFTD should be recognised and rejected by the Tasmanian devil's immune system as a foreign graft, but it appears to be invisible. This project aims to discover if re-expression of MHC molecules allows DFTD cells to be recognised as an allograft and ultimately be killed by the devil immune system. In vitro cell culture techniques and flow cytometry will be used to examine responses. The demonstration that tumour cells can be recognized by cytotoxic T cells will aid the design of immune based strategies for prevention and therapy.
Funding
University of Tasmania Foundation Inc ($28,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Lyons AB; Woods GM
Year
2014
The immune system of the Tasmanian Devil and how it is affected by Devil Facial Tumour Disease (DFTD) (2014 - 2016)$21,600
Description
The aims of this project are: to determine the ratio of T lymphocyte subsets (CD4 and CD8) in healthy devils and if this is altered in diseased devils; to assess the serum concentrations of immunoglobulins (IgG and IgM) in healthy devils and if this is altered in diseased devils; to survey serum samples from healthy and diseased devils to identify antibodies to DFTD, which will serve as a biomarker for natural immunity to DFTD.
Funding
Holsworth Wildlife Research Endowment ($21,600)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM; Pye Ruth
Period
2014 - 2016
Co-signalling immunotherapy to treat DFTD (2014)$20,000
Description
Immunotherapies targeting immune signalling molecules have recently yielded unprecedented results in treating human cancer. The genes targeted in these ground-breaking trials have been identified in devils; this study will assess the potential for translating the already proven human therapies into treatment for the DFTD.
Funding
University of Tasmania Foundation Inc ($20,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Flies Andrew; Woods GM
Year
2014
Co-signalling immunotherapy to treat DFTD (2014 - 2016)$99,360
Description
Immunotherapies targeting immune signalling molecules have recently yielded unprecedented results in treating human cancer. The genes targeted in these ground-breaking trials have been identified in devils. This study will assess the potential for translating the already proven human therapies into a treatment for the DFTD. This research aims to determine if DFTD cells can be modified to induce cytotoxic lymphocyte activity which has the potential to be used as therapy to treat devil facial tumour disease.
Funding
Morris Animal Foundation ($99,360)
Scheme
Fellowship
Administered By
University of Tasmania
Research Team
Woods GM; Flies Andrew
Period
2014 - 2016
Development of methods for therapeutic vaccines against Devil facial tumour disease (2013)$34,971
Funding
University of Tasmania Foundation Inc ($34,971)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Brown GK; Woods GM
Year
2013
Host-tumour Interplay in Tasmanian Devils with Devil Facial Tumour Disease: Can Immune Cells be Harnessed for Therapy? (2013 - 2015)$380,000
Description
Tasmanian devils only exist in Tasmania and Devil Facial Tumour Disease, an infectious cancer, could cause the extinction of the Tasmanian devil. This project will determine if Devil Facial Tumour Disease reduces the effectiveness of the devils immune system and test if activated immune cells can protect against this disease.
Funding
Australian Research Council ($380,000)
Scheme
Grant-Discovery Projects
Administered By
University of Tasmania
Research Team
Woods GM; Lyons AB; Corcoran L
Period
2013 - 2015
Grant Reference
DP130100715
Vaccination as a potential strategy to protect Tasmanian devil against extinction in the wild due to a transmissible cancer (2013)$54,800
Funding
Mazda Foundation ($54,800)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM
Year
2013
Development of an immune enhancing vaccine to protect Tasmanian devils against a contagious cancer (2013 - 2015)$412,912
Description
The iconic Tasmanian devil is threatened with extinction from a uniformly fatal transmissible facial cancer. This project builds on existing research on the cancer cells that can be recognised by the devil immune system. It will develop and test a vaccine against the tumour, which will ultimately protect devils in the wild.
Funding
Australian Research Council ($412,912)
Scheme
Grant-Linkage Projects Round 1
Administered By
University of Tasmania
Research Team
Woods GM; Lyons AB
Period
2013 - 2015
Grant Reference
LP130100218
Activation of innate immune cells to promote a protective immune response against devil facial tumour cells in murine model of DFTD (2013)$35,000
Description
This project will determine if stimulants of the innate immune system can protect against DFTD. Consequently it will assist in the development of a vaccine. Due to the limited availability of Tasmanian devils for vaccine research, the research will utilise a mouse model of DFTD.
Funding
University of Tasmania Foundation Inc ($35,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Woods GM; Bettiol SS; Pinfold T
Year
2013
Maintenance of a post-insurance population of Tasmanian devils for research and welfare (2013)$31,031
Description
Vaccine related research requires access to healthy devils that can be immunised and analysed for immune responses. This project will contribute to keeping the Fern Tree devil research facility functional to maintain nine healthy devils for a 6-month period.
Funding
University of Tasmania Foundation Inc ($31,031)
Scheme
Grant-Tasmanian Devil Management Project Grant
Administered By
University of Tasmania
Research Team
Woods GM
Year
2013
Novel strategies to protect Tasmanian devils against Tasmanian Devil Facial Tumour Disease (2012 - 2013)$30,000
Funding
Donation via University of Tasmania Foundation ($30,000)
Scheme
Donation - Individual
Administered By
University of Tasmania
Research Team
Woods GM; Kreiss A
Period
2012 - 2013
MHC-I expression on DFTD tumour cells and monoclonal antibodies as a strategy to induce and analyse an immune response to DFTD (2012)$29,736
Funding
University of Tasmania Foundation Inc ($29,736)
Scheme
Award-Eric Guiler Foundation
Administered By
University of Tasmania
Research Team
Kreiss A; Woods GM; Lyons AB; Tovar Lopez CD
Year
2012
New vaccination strategy to protect Tasmanian Devils against the devil facial tumour disease (2012 - 2013)$35,000
Funding
University of Tasmania Foundation Inc ($35,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Kreiss A; Woods GM
Period
2012 - 2013
Selection of devil facial tumour associated antigens as a tool for the development of a prophylactic vaccine (2012)$33,661
Funding
University of Tasmania Foundation Inc ($33,661)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Tovar Lopez CD; Woods GM
Year
2012
Cytotoxic devil lymphocytes as a therapy against Devil Facial Tumour Disease (2012)$9,900
Funding
The Select Foundation ($9,900)
Scheme
Grant-Small Grants Scheme
Administered By
University of Tasmania
Research Team
Woods GM; Pinfold T; Brown GK
Year
2012
Gene therapy in Human Cells Mediated by Integrase from a Yeast Retrotransposon (2011)$6,500
Funding
David Collins Leukaemia Foundation ($6,500)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM; Casey NP
Year
2011
Upgrade of the flow cytometry facility of the Menzies Research Institute with a multi-parameter analytical flow cytometer CyAn ADP 9 Color for key applications (2011)$75,000
Funding
Clive & Vera Ramaciotti Foundation ($75,000)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
Korner H; McMorran BJ; Woods GM; Holloway AF; West AK
Year
2011
Characterisation of DFTD tumour proteins eliciting immune responses in Tasmanian devils (2011)$26,500
Funding
University of Tasmania Foundation Inc ($26,500)
Scheme
Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
Tovar Lopez CD; Woods GM; Kreiss A
Year
2011
Evaluation of the ability of vitamin D and metallothionein to protect against UV-radiation induced skin cancer (2011)$70,000
Funding
Cancer Council of Tasmania ($70,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; West AK; McGee HM; Muller HK
Year
2011
Production of monoclonal antibodies to identify important immune cell populations of the Tasmanian Devil (2011)$29,600
Funding
University of Tasmania Foundation Inc ($29,600)
Scheme
Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
Woods GM; Corcoran L; Belov K
Year
2011
Infrastructure Grant - Expansion of captivity facility in Fern Tree (2010)$13,800
Funding
University of Tasmania Foundation Inc ($13,800)
Scheme
Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
Kreiss A; Woods GM
Year
2010
Use of a murine model to investigate devil facial tumour disease (2010)$24,000
Funding
University of Tasmania Foundation Inc ($24,000)
Scheme
Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
Kreiss A; Woods GM
Year
2010
Assessing the role of metallothionein in the development of non-melanoma skin cancer (2010)$5,000
Funding
Royal Hobart Hospital Research Foundation ($5,000)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
McGee HM; West AK; Woods GM; Bennett WR
Year
2010
Role of vitamin D3 and metallothionein in protection against melanoma (2010)$86,250
Funding
Cancer Council of Tasmania ($86,250)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Chung RS; Walker Graeme; Muller HK
Year
2010
Greg Woods - Discretionary Account (2009)$10,000
Funding
Menzies Institute for Medical Research ($10,000)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Woods GM
Year
2009
Investigating the role of metallothionein in ultraviolet radiation-induced skin cancer (2009)$9,200
Funding
Cancer Council of Tasmania ($9,200)
Scheme
Grant-Small
Administered By
University of Tasmania
Research Team
McGee HM; Pankhurst MW; Chung RS; Woods GM
Year
2009
The involvement of tumour cytokine production in the pathogenesis of Tasmanian Devil (Sarcophilus Harrisii) Facial Tumour Disease (DFTD) (2009)$17,700
Funding
University of Tasmania Foundation Inc ($17,700)
Scheme
Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
McGee HM; Kreiss A; Woods GM
Year
2009
Influence of vitamin D and gender on UVB-induced DNA damage, immunoregulation and development of melanoma (2009)$54,400
Funding
Cancer Council of Tasmania ($54,400)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2009
An Immunological and Immunogenetic Approach to Understand and to Protect Tasmanian Devils against Devil Facial Tumour Disease (2009 - 2011)$490,000
Funding
Australian Research Council ($400,000)
Scheme
Grant-Linkage Projects Round 1
Administered By
University of Tasmania
Research Team
Woods GM; Belov K; Kreiss A
Period
2009 - 2011
Grant Reference
LP0989727
Save the Tasmanian Devil - identification of genetically resistant devils (2009)$65,694
Funding
Turner Foundation Inc ($65,694)
Scheme
Grant-Endangered Species Program
Administered By
University of Tasmania
Research Team
Woods GM
Year
2009
Establishment of a mouse model to study the biology of Devil Facial Tumour Disease (DFTD) (2009)$20,255
Funding
University of Tasmania Foundation Inc ($20,255)
Scheme
Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
Woods GM; Kreiss A; Tovar Lopez CD; Shellie RA; Hilder EF; Breadmore MC
Year
2009
Flow cytometer and ancillary assay kits (2008)$150,000
Funding
Royal Hobart Hospital Research Foundation ($150,000)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
Walters EH; Woods GM
Year
2008
Establishment of a Confocal/multiphoton Microscope for Imaging of Living Systems (2008)$300,000
Funding
Australian Research Council ($300,000)
Scheme
Grant-Linkage Infrastructure
Administered By
University of Tasmania
Research Team
Vickers JC; Foote SJ; Small DH; Walters EH; Hallegraeff GM; West AK; Chung RS; Woods GM; Dickson TC; Nowak BF; Bolch CJS
Year
2008
Grant Reference
LE0882701
The effect of UV radiation and vitamin D deficiency on the development of the skin immune system (2008)$50,000
Funding
Cancer Council of Tasmania ($50,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2008
Silencing the AML1/ETO fusion gene as a treatment strategy for acute myeloid leukaemia (2008)$7,704
Funding
Clifford Craig Foundation ($7,704)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM; Holloway AF; Casey NP
Year
2008
Professional Development Application - N Casey (2008)$400
Funding
David Collins Leukaemia Foundation ($400)
Scheme
Award-Professional Development
Administered By
University of Tasmania
Research Team
Woods GM; Casey NP
Year
2008
Immunohistochemistry as a tool to search for evidence of immunity against Devil Facial Tumour Disease (DFTD) (2008)$16,657
Funding
University of Tasmania Foundation Inc ($16,657)
Scheme
Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
Woods GM; Kreiss A
Year
2008
Analysis of Devil Tumour Disease to identify unique tumour antigens for diagnosis and vaccination (2008)$16,251
Funding
University of Tasmania Foundation Inc ($16,251)
Scheme
Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
Woods GM; Kreiss A; Tovar Lopez CD
Year
2008
Platypus Partnership - A Community and Science-based Conservation Programme (2007 - 2008)$50,000
Funding
Natural Heritage Trust ($50,000)
Scheme
Grant-Natural Resource Management, Northern Region
Administered By
University of Tasmania
Research Team
Geraghty DP; Stewart NJ; Woods GM; Tristram SG; Forteath GN
Period
2007 - 2008
Effects of UV radiation and vitamin D deficiency on the development of the skin immune system (2007)$35,000
Funding
Cancer Council of Tasmania ($35,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2007
Investigation of the potential of lentivirus-delivered shRNA in inhibiting the proliferation of human leukemic cells in vivo (2007)$10,514
Funding
David Collins Leukaemia Foundation ($10,514)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM; Casey NP
Year
2007
An immunological and immunogenetic approach to protect Tasmanian devils against Devil Facial Tumour Disease (DFTD) (2007)$23,524
Funding
University of Tasmania Foundation Inc ($23,524)
Scheme
Donation-Dr Eric Guiler Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
Woods GM; Kreiss A
Year
2007
Tasmanian Devil Research Scholarship - A Kreiss (2007)$19,321
Funding
Qantas Airways Ltd ($19,321)
Scheme
Scholarship-Tasmanian Devil Research
Administered By
University of Tasmania
Research Team
Woods GM; Kreiss A
Year
2007
Evaluation of Abalone Haemocyanin and Blood Extracts on the Immune Response and other related health parameters (2006 - 2007)$160,826
Funding
Associate Professor Greg Woods ($160,826)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Woods GM; Bettiol SS; Carroll V
Period
2006 - 2007
Tasmanian Wildlife Research Advisory Committee Devil Facial Tumour grant (2006 - 2008)$63,132
Funding
Donation via University of Tasmania Foundation ($63,132)
Scheme
Donation - Individual
Administered By
University of Tasmania
Research Team
Woods GM
Period
2006 - 2008
Mucor Amphibiorum Infection of Platypus (Ornithorhynchus anatinus) in Tasmania - What is the Threat to Platypus and Other Wildlife? (2006)$10,000
Funding
Norske-Skog (Australasia) Pty Ltd ($10,000)
Scheme
Agreement
Administered By
University of Tasmania
Research Team
Geraghty DP; Stewart NJ; Woods GM; Forteath GN; Langstaff I; Connolly J
Year
2006
Microscopic, Biochemical and Functional Characterisation of NK Cell Invasion into Tumour Cells (2006)$51,600
Funding
Cancer Council of Tasmania ($51,600)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Trambas CM; Woods GM
Year
2006
Long Term Effects of UV-B Irradiation on the Developing Skin Immune System (2006)$37,750
Funding
Cancer Council of Tasmania ($37,750)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2006
Analysis of a Lentivirus-delivered shRNA to Prevent Leukaemic Cell Growth (2006)$10,000
Funding
David Collins Leukaemia Foundation ($10,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM; Casey NP
Year
2006
Paul Mackay Bolton Scholarship for Cancer Research (2006)$18,750
Funding
Royal Australasian College of Surgeons ($18,750)
Scheme
Scholarship
Administered By
University of Tasmania
Research Team
Woods GM; Castley A
Year
2006
Marinova Consultancy (2005 - 2006)$21,000
Funding
Marinova Pty Ltd ($21,000)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Woods GM
Period
2005 - 2006
The Skin Immune System in Cutaneous Carcinogenesis (2005 - 2007)$74,895
Funding
National Health & Medical Research Council ($74,895)
Scheme
Scholarship-Postgraduate:Medical
Administered By
University of Tasmania
Research Team
Woods GM; Malley RC
Period
2005 - 2007
Grant Reference
352624
Microscopic, Biochemical and Functional Characterisation of Natural Killer Cell Invasion into Tumour Target Cells - Emperipolesis (2005)$40,000
Funding
Cancer Council of Tasmania ($40,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Trambas CM; Woods GM
Year
2005
Long Term Effects of UVB Irradiation on Neonatal Langerhans Cells (2005)$35,000
Funding
Cancer Council of Tasmania ($35,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2005
Vitamin D in the Skin Immune System (2005)$14,980
Funding
Arthritis Australia ($14,980)
Scheme
Grant-Sir Warwick Fairfax Memorial
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2005
Development of the Skin Immune System and the Effect of Exposure to Sunlight (2005)$12,855
Funding
Royal Hobart Hospital Research Foundation ($12,855)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2005
Vitamin D Deficiency in Skin Cancer Development (2005)$12,000
Funding
Royal Hobart Hospital Research Foundation ($12,000)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK; Malley RC
Year
2005
Spectramax M2 Multimode ELISA Plate Reader with Softmax Pro Software (2005)$33,019
Funding
National Health & Medical Research Council ($33,019)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
Walters EH; Reid DW; Woods GM; Dickson TC
Year
2005
Grant Reference
264668
Langerhans Cells: From Birth to Maturity (2005)$4,800
Funding
Royal Hobart Hospital Research Foundation ($4,800)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Woods GM; Castley A
Year
2005
Skin Cancer and non-Hodgkin's Lymphoma: What is the Risk of Developing both Primary Cancers in Tasmania? (2004)$10,000
Funding
Cancer Council of Tasmania ($10,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Venn A; Blizzard CL; Dwyer T; Woods GM
Year
2004
A Pilot Study to Examine Biological, Lifestyle and Genetic Risk Factors Associated with the Development of Multiple Non-melanoma Skin Cancers (2004)$22,000
Funding
University of Tasmania ($22,000)
Scheme
Grant-Institutional Research Scheme
Administered By
University of Tasmania
Research Team
Venn A; Dwyer T; Blizzard CL; Woods GM; Muller HK; Dickinson JL
Year
2004
Immunosuppression by Carcinogen Induced Immature Dendritic Cells: Gene Activation and Intervention Strategies (2004)$30,000
Funding
Cancer Council of Tasmania ($30,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2004
A Proteomics Approach to the Identification of Novel Immune Suppressor Factors in Neonatal Skin (2004)$7,273
Funding
Royal Hobart Hospital Research Foundation ($7,273)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Woods GM; Lord RJ
Year
2004
Shandon Cytopsin 4 Cytocentrifuge (2004)$13,898
Funding
National Health & Medical Research Council ($13,898)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
Walters EH; Reid DW; Woods GM; Wood-Baker R
Year
2004
Grant Reference
264536
The Molecular Basis of Ceramide-Mediated Growth Arrest and Terminal Differentiation (2003)$40,000
Funding
Cancer Council of Tasmania ($40,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Ragg SJ; Woods GM; Lowenthal RM
Year
2003
The Molecular Basis of Ceramide-Mediated Growth Arrest and Terminal Differentiation (2003)$33,300
Funding
David Collins Leukaemia Foundation ($33,300)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Ragg SJ; Woods GM; Lowenthal RM
Year
2003
A Pilot Study to Examine Biological, Lifestyle and Genetic Risk Factors Associated with the Development of Second and Subsequent Non-melanoma Skin Cancers in People with a History of Skin Cancer (2003)$18,000
Funding
Cancer Council of Tasmania ($18,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Venn A; Dwyer T; Blizzard CL; Woods GM; Muller HK; Dickinson JL
Year
2003
Immunosuppression by Carcinogen Induced Immature Dendritic Cells: Signalling Molecules, Potential Pathways and Intervention Strategies (2003)$30,000
Funding
Cancer Council of Tasmania ($30,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK; Wang Z
Year
2003
Molecular Identification and Characterisation of Mini P-glycoproteins (2002)$13,636
Funding
Royal Hobart Hospital Research Foundation ($13,636)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Trambas CM; Woods GM
Year
2002
Molecular Identification and Characterisation of Mini P-glycoproteins (2002)$29,720
Funding
David Collins Leukaemia Foundation ($29,720)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Trambas CM; Woods GM
Year
2002
Immunosuppression by Carcinogen Induced Immature Dendritic Cells: Signalling Molecules, Potential Pathways and Intervention Strategies (2002)$40,000
Funding
Cancer Council of Tasmania ($40,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Wang Zenim; Muller HK
Year
2002
Analysis of Reduced IFN-y and Increased IL-12 (p40) as a Mechanism Contributing to Carcinogen Induced Immunosuppression (2002)$10,910
Funding
Royal Hobart Hospital Research Foundation ($10,910)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2002
Characterising Carcinogen Induced Immunosuppression and Tumor Escape (2001)$31,530
Funding
Cancer Council of Tasmania ($31,530)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Doherty KV; Muller HK
Year
2001
Analysis of Mini-P-Glycoprotein in Normal and Leukaemic Cells (2001)$18,833
Funding
David Collins Leukaemia Foundation ($18,833)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM
Year
2001
Denskometer/2D Database Analysis & IEF System (Proteomics) (2001)$8,000
Funding
National Health & Medical Research Council ($8,000)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
2001
Antigen Handling Costimulatory Molecule Expression and Intracellular Signalling of IL-10 Induced Human Tolerogenic Dendritic Cells (2001)$11,400
Funding
Royal Hobart Hospital Research Foundation ($11,400)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Woods GM; Hassan G; Muller HK
Year
2001
Characterisation and Molecular Cloning of a Novel P-glycoprotein Homologue (2000)$25,000
Funding
David Collins Leukaemia Foundation ($25,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM
Year
2000
Tolerogenic dendritic cells as a potential therapy for autoimmune disease (combined with 106924: Immature cells induce suppressive immune responses) (2000 - 2002)$339,688
Funding
National Health & Medical Research Council ($339,688)
Scheme
Grant-Project Three Year
Administered By
University of Tasmania
Research Team
Woods GM; Doherty KV; Muller HK; Toh BH
Period
2000 - 2002
Grant Reference
137
Characterization and Molecular Cloning of a Novel and Ubiquitous P-glycoprotein Homologue (2000)$26,800
Funding
Australian Research Council ($26,800)
Scheme
Grant-Small
Administered By
University of Tasmania
Research Team
Woods GM; West AK
Year
2000
Carcinogen Induced Immunosuppression: A Critical Role for Immature Epidermal Langerhans Cells (1999)$29,000
Funding
Cancer Council of Tasmania ($29,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Doherty KV; Woods GM; Muller HK
Year
1999
Induction of immuno-suppression by functionality immature Langerhans cells (1999)$3,500
Funding
Clifford Craig Medical Research Trust/UTAS ($3,500)
Scheme
Grant-Collaborative
Administered By
University of Tasmania
Research Team
Doherty KV; Muller HK; Woods GM
Year
1999
Funding for Small Equipment - Microradiance Laser Confocal Imaging System (1999)$50,000
Funding
Australian Cancer Research Foundation ($50,000)
Scheme
Grant-Tasmanian Small Equipment
Administered By
University of Tasmania
Research Team
Woods GM; Doherty KV; Vickers JC; Muller HK
Year
1999
Identifying a Specific and Sensitive Probe for Assessing P-glycoprotein Function (1999)$18,000
Funding
Cancer Council of Tasmania ($18,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Trambas CM
Year
1999
Tolerogenic dendritic cells as a potential therapy for autoimmune disease (1999)$3,345
Funding
Clifford Craig Medical Research Trust/UTAS ($3,345)
Scheme
Grant-Collaborative
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK; Toh BH
Year
1999
Down-regulation of Autoimmunity Utilising Modified Dendritic Cells (1998)$5,500
Funding
Clifford Craig Medical Research Trust/UTAS ($5,500)
Scheme
Grant-Collaborative
Administered By
University of Tasmania
Research Team
Muller HK; Toh BH; Woods GM
Year
1998
Development of a Laser Confocal Microscope System (1998)$25,000
Funding
Clive & Vera Ramaciotti Foundation ($25,000)
Scheme
Grant-Establishment
Administered By
University of Tasmania
Research Team
Vickers JC; Woods GM
Year
1998
Immunology of healthy and diseased platypus (Ornithorhynchus anatinus). (1997 - 1999)$36,000
Funding
Australian Research Council ($36,000)
Scheme
Grant-Small
Administered By
University of Tasmania
Research Team
Munday BL; Woods GM
Period
1997 - 1999
Towards a Novel Differentiation Therapy of Leukemia Using Ceramide (1997 - 2001)$118,549
Funding
Cancer Council of Tasmania ($118,549)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Ragg SJ; Lowenthal RM
Period
1997 - 2001
Towards a Novel Differentiation Therapy of Leukaemia using Ceramide (1997 - 2001)$144,633
Funding
David Collins Leukaemia Foundation ($144,633)
Scheme
Scholarship
Administered By
University of Tasmania
Research Team
Ragg SJ; Woods GM; Lowenthal RM
Period
1997 - 2001
Analysis of antigen presenting cells and T cells during carcinogen induced immunosuppression. (1997 - 1999)$161,896
Funding
National Health & Medical Research Council ($161,896)
Scheme
Grant-MRC Project
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Period
1997 - 1999
Grant Reference
971331
Superspeed Centrifuge. (1997)$20,000
Funding
National Health & Medical Research Council ($20,000)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
Woods GM; Kirov SM; Lyons AB; Muller HK
Year
1997
Grant Reference
971378
Detrimental alterations of antigen presenting cells and T cells during carcinogenesis (1997 - 1998)$38,000
Funding
Cancer Council of Tasmania ($38,000)
Scheme
Grant-Cancer Research
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Period
1997 - 1998
Superspeed Refrigerated Centrifuge (1997)$14,507
Funding
Clive & Vera Ramaciotti Foundation ($14,507)
Scheme
Grant-Establishment
Administered By
University of Tasmania
Research Team
Woods GM; Kirov SM
Year
1997
EPICS large laser elite flow cytometer (1996)$30,000
Funding
Clive & Vera Ramaciotti Foundation ($30,000)
Scheme
Grant-Establishment
Administered By
University of Tasmania
Research Team
Muller HK; Woods GM
Year
1996
Elite workstation for Flow Cytometry (single user) (1996)$10,000
Funding
National Health & Medical Research Council ($10,000)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
Woods GM; Dandie GW; Lyons AB; Muller HK
Year
1996
Grant Reference
961451
Involvement of P-glycoprotein in the resistance to cancer chemotherapy and cytotoxicity (1996 - 1998)$31,600
Funding
David Collins Leukaemia Foundation ($31,600)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM
Period
1996 - 1998
Cutaneous tolerance induction. Down-regulation of autoimmunity (1995 - 1997)$186,141
Funding
National Health & Medical Research Council ($186,141)
Scheme
Grant-MRC Project
Administered By
University of Tasmania
Research Team
Muller HK; Toh BH; Woods GM
Period
1995 - 1997
Grant Reference
951249
Biohazard Cabinet (1995)$14,000
Funding
National Health & Medical Research Council ($14,000)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
Muller HK; Kirov SM; Woods GM; Vickers JC
Year
1995
Grant Reference
951382
Analysis of Langerhans cell function during chemically and physically induced carcinogenesis (1995)$15,000
Funding
Tasmanian Cancer Council ($15,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
1995
Multidrug resistance and natural killer cells (1995)$10,000
Funding
David Collins Leukaemia Foundation ($10,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM
Year
1995
Analysis of Langerhans cell function during chemically and physically induced carcinogenesis (1994)$16,619
Funding
Tasmanian Cancer Council & W P Holman Clinics ($16,619)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM; Muller HK
Year
1994
Refrigerated centrifuge for immunological and microbiological studies (1992)$18,252
Funding
National Health & Medical Research Council ($18,252)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
Muller HK; Woods GM; Kirov SM
Year
1992
Grant Reference
921213
Langerhans cells and carcinogens (1992 - 1993)$50,000
Funding
Tasmanian Cancer Council ($50,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM
Period
1992 - 1993
Ultracentrifuge for molecular biological studies (1990)$25,775
Funding
National Health & Medical Research Council ($25,775)
Scheme
Grant-Equipment
Administered By
University of Tasmania
Research Team
West AK; Clark MG; Woods GM
Year
1990
Grant Reference
901080
Molecular biological studies of leukaemia (1990 - 1994)$91,844
Funding
David Collins Leukaemia Foundation ($91,844)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Woods GM
Period
1990 - 1994
Effects of carcinogens on NK cells and other immune defence cells (1990)$4,000
Funding
University of Tasmania ($4,000)
Scheme
Grant-New Staff Research Priming
Administered By
University of Tasmania
Research Team
Woods GM
Year
1990
Localisation of genes responsible for multiple endocrine neoplasia type-1 (1990)$10,000
Funding
Tasmanian Cancer Council ($10,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Wilkinson S; Woods GM
Year
1990

Research Supervision

Prof Woods is an outstanding supervisor with an endless supply of energy, enthusiasm and patience. His impressive reputation has attracted him numerous honours, masters and PhD candidates. With over 20 PhD candidates successfully supervised to completion, Prof Woods has facilitated many successful careers.

Current

6

Completed

29

Current

DegreeTitleCommenced
PhDImmune Recognition of Devil Facial Tumour Disease by the Tasmanian Devil2013
PhDRedefining the Role of Tumour Necrosis Factor in Macrophage Differentiation and Effector Function in Bacterial and Tumour Defences2014
PhDIn Vitro Identification of Vaccination Strategies for the Stimulation of an Immune Response against Devil Facial Tumour Disease2014
PhDInvestigation of Natural Killer Cells in Devil Facial Tumour Disease2016
PhDInsertion of Suicide Genes into DFTD Cancer Cells as Mechanism to Improve Vaccine Efficiency2017
PhDVaccination-induced Resistance Against DFTD in Tasmanian Devils: Immunisation approaches to enhance immune responses to DFTD2017

Completed

DegreeTitleCompleted
PhDThe Anti-Cancer Activity of the Natural Product, Fucoidan, in Haematological Malignancies
Candidate: Farzaneh Atashrazm
2016
PhDDevil Face Tumour Disease: In vivo studies in mice
Candidate: Terry Lee Pinfold
2014
PhDManipulating the Immune Response of Tasmanian Devils to Target Devil Facial Tumour Disease
Candidate: Gabriella Kathleen Brown
2013
PhDInsights into the Nature and Immune Escape of a Transmissible Cancer in Tasmanian Devils
Candidate: Cesar Dario Tovar Lopez
2012
UnknownImmune Reconstitution in HIV-I Infection: The Effects of Antiretroviral and Immune Therapy
Candidate: Ann Kathleen Sullivan
2011
PhDDifferential Expression of the GM-CSF Gene in the Immune System is Regulated By Epigenetic Factors
Candidate: Owen Ralph Sprod
2011
PhDThe Therapeutic Potential of Lentivector-Delivered RNAi
Candidate: Nicholas Paul Casey
2010
PhDDietary Vitamin D3, the Skin Immune System and Implications for Skin Cancer
Candidate: Roslyn Christine Malley
2010
PhDThe Immune Responses of the Tasmanian Devil (Sarchphilus harrissi) and the Devil Facial Tumour Disease
Candidate: Alexandre Kreiss
2009
PhDNeonatal Exposure to Ultraviolet Radiation: Implications for Development and Function of the Skin Immune System
Candidate: Heather Margaret McGee
2009
PhDProteomic Analysis of Breast Cancer
Candidate: Kylie Maree Roberts
2009
PhDRegulation of Gene Expression by the RUNX1 Transcription Factor
Candidate: Phillippa Claire Oakford
2008
PhDIron and Pseudomonas aeruginosa Chronic Infection
Candidate: Che Yanon O'May
2008
PhDClinical Haemopoietic Implications of Fucoidan Treatment
Candidate: Mohammad Rassem Irhimeh
2008
MastersReducing the Toxicity of Autologous Haemopoetic Stem Cell Transplants
Candidate: Nicole Eileen Wright
2006
PhDAnalysis of Antigen Handling by Epidermal Langerhans' Cells during the Early Neonatal Period
Candidate: Bernadette Mary Bellette
2005
PhDUnique Features of the Neonatal Immune System
Candidate: Campbell Charles Simpson
2005
PhDThe Role of Ceramide in Growth arrest and terminal differentiation of Human Leukaemia Cells
Candidate: Charles Edward Connor
2004
PhDTHE MOLECULAR GENETICS OF FAMILIAL NON-MEDULLARY THYROID CANCER
Candidate: James Dowling McKay
2002
PhDThe epidemiology of ulcerative mycosis of the platypus
Candidate: Niall John Stewart
2001
PhDTherapeutic interventions in Alzheimer's disease
Candidate: Paul Anthony Adlard
2001
PhDRe-evaluation of P-glycoprotein in Natural Killer Cells
Candidate: Christina Margaret Trambas
2001
PhDThe CNS injury response and its relationship to Alzheimer's Disease
Candidate: Carolyn King
2001
PhDDiseases and immunity in perameles gunnii
Candidate: Silvana Santina Bettiol
2000
PhDThe Cellular Mechanism Underlying Neuronal Changes in Alzheimer's Disease
Candidate: Tracey Christine Dickson
2000
PhDInvestigation of the effect of chemical carcinogens upon epidermal and dermal cell populations
Candidate: Michael John Rist
2000
PhDRegulation of auto immune diseases
Candidate: Yi Peng Chen
1998
MastersChange in the skin immune system during the development of skin cancer
Candidate: Miao Miao Qu
1995
PhDTitle: Expression of Nuclear-Acting Early-Response Genes in the Rat Heart: implications for cardiac hypertrophy
Candidate: Ross Duncan Hannan
1994